BREAKTHROUGH T1D: Form 990, tax year 2021

View the entire original 990 at ProPublica ↗

Organization: BREAKTHROUGH T1D (EIN 23-1907729)
Tax period: 2021-07-01 to 2022-06-30
Filed: 2023-03-31
IRS object ID: 202310909349300306
Schema version: 2021v4.2
Source: Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header
Form 990
Schedule A
Schedule B
Schedule C
Schedule D
Schedule F
Schedule G
Schedule I
Schedule J
Schedule L
Schedule M
Schedule O
Schedule R

Return header ReturnHeader

Field	Value	IRS element (for citing)
Return	2023-03-31T07:03:21-05:00	ReturnTs
Tax Period End	2022-06-30	TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Field	Value	IRS element (for citing)
Preparer Firm EIN	135565207	PreparerFirmEIN

Preparer Firm Name PreparerFirmName

Field	Value	IRS element (for citing)
Business Name Line1	KPMG LLP	BusinessNameLine1Txt

Preparer US Address PreparerUSAddress

Field	Value	IRS element (for citing)
Address Line1	345 PARK AVENUE	AddressLine1Txt
City	NEW YORK	CityNm
State Abbreviation	NY	StateAbbreviationCd
ZIP	101540102	ZIPCd

Field	Value	IRS element (for citing)
Return Type	990	ReturnTypeCd
Tax Period Begin	2021-07-01	TaxPeriodBeginDt

Filer Filer

Field	Value	IRS element (for citing)
EIN	231907729	EIN

Business Name BusinessName

Field	Value	IRS element (for citing)
Business Name Line1	JDRF INTERNATIONAL	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Business Name Control	JDRF	BusinessNameControlTxt
Phone	8005332873	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	200 VESEY STREET 28TH FLOOR	AddressLine1Txt
City	NEW YORK	CityNm
State Abbreviation	NY	StateAbbreviationCd
ZIP	10281	ZIPCd

Business Officer BusinessOfficerGrp

Field	Value	IRS element (for citing)
Person	ROBERT KING	PersonNm
Person Title	CFAO	PersonTitleTxt
Phone	2124797550	PhoneNum
Signature	2023-03-29	SignatureDt
Discuss With Paid Preparer	Yes (1)	DiscussWithPaidPreparerInd

Signing Officer SigningOfficerGrp

Person Full Name PersonFullName

Field	Value	IRS element (for citing)
Person First	ROBERT	PersonFirstNm
Person Last	KING	PersonLastNm

Field	Value	IRS element (for citing)
SSN	999009999	SSN

Preparer Person PreparerPersonGrp

Field	Value	IRS element (for citing)
Preparer Person	DEVIN L DUNCAN	PreparerPersonNm
PTIN	P01249521	PTIN
Phone	2127589700	PhoneNum
Preparation	2023-03-28	PreparationDt

Additional Filer Information AdditionalFilerInformation

Trusted Customer TrustedCustomerGrp

Field	Value	IRS element (for citing)
Trusted Customer	3	TrustedCustomerCd
Authentication Assurance Level	AAL1	AuthenticationAssuranceLevelCd
Identity Assurance Level	IAL1	IdentityAssuranceLevelCd

Field	Value	IRS element (for citing)
Tax	2021	TaxYr
Build TS	2023-04-26 12:10:37Z	BuildTS

Form 990 IRS990

Field	Value	IRS element (for citing)
Principal Officer	AARON KOWALSKI	PrincipalOfficerNm

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	200 VESEY STREET	AddressLine1Txt
City	NEW YORK	CityNm
State Abbreviation	NY	StateAbbreviationCd
ZIP	10281	ZIPCd

Field	Value	IRS element (for citing)
Gross Receipts	$379,709,090	GrossReceiptsAmt
Group Return For Affiliates	0	GroupReturnForAffiliatesInd
Organization501c3	Yes (X)	Organization501c3Ind
Website Address	WWW.JDRF.ORG	WebsiteAddressTxt
Type Of Organization Corp	Yes (X)	TypeOfOrganizationCorpInd
Formation	1970	FormationYr
Legal Domicile State	PA	LegalDomicileStateCd
Activity Or Mission	IMPROVING LIVES BY ACCELERATING BREAKTHROUGHS TO CURE, PREVENT AND TREAT T1D. SEE SCHEDULE O.	ActivityOrMissionDesc
Voting Members Governing Body	15	VotingMembersGoverningBodyCnt
Voting Members Independent	14	VotingMembersIndependentCnt
Total Employee	496	TotalEmployeeCnt
Total Volunteers	235000	TotalVolunteersCnt
Total Gross UBI	$96,472	TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm	$72,762	NetUnrelatedBusTxblIncmAmt
PY Contributions Grants	$190,647,071	PYContributionsGrantsAmt
CY Contributions Grants	$205,076,492	CYContributionsGrantsAmt
PY Program Service Revenue	$0	PYProgramServiceRevenueAmt
CY Program Service Revenue	$20,503,582	CYProgramServiceRevenueAmt
PY Investment Income	$28,497,433	PYInvestmentIncomeAmt
CY Investment Income	$10,283,819	CYInvestmentIncomeAmt
PY Other Revenue	$3,878,139	PYOtherRevenueAmt
CY Other Revenue	$2,731,612	CYOtherRevenueAmt
PY Total Revenue	$223,022,643	PYTotalRevenueAmt
CY Total Revenue	$238,595,505	CYTotalRevenueAmt
PY Grants And Similar Paid	$28,823,131	PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid	$72,152,705	CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members	$0	PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members	$0	CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid	$53,217,471	PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid	$57,146,058	CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns	$46,678	PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns	$1,388,063	CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense	$28,287,437	CYTotalFundraisingExpenseAmt
PY Other Expenses	$33,383,167	PYOtherExpensesAmt
CY Other Expenses	$32,202,373	CYOtherExpensesAmt
PY Total Expenses	$115,470,447	PYTotalExpensesAmt
CY Total Expenses	$162,889,199	CYTotalExpensesAmt
PY Revenues Less Expenses	$107,552,196	PYRevenuesLessExpensesAmt
CY Revenues Less Expenses	$75,706,306	CYRevenuesLessExpensesAmt
Total Assets BOY	$361,315,226	TotalAssetsBOYAmt
Total Assets EOY	$389,461,665	TotalAssetsEOYAmt
Total Liabilities BOY	$100,761,301	TotalLiabilitiesBOYAmt
Total Liabilities EOY	$94,551,427	TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY	$260,553,925	NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY	$294,910,238	NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part III	Yes (X)	InfoInScheduleOPartIIIInd
Mission	SEE SCHEDULE O.	MissionDesc
Significant New Program Srvc	0	SignificantNewProgramSrvcInd
Significant Change	0	SignificantChangeInd
Expense	$72,152,705	ExpenseAmt
Grant	$72,152,705	GrantAmt
Desc	RESEARCH FUNDING - FOR THE FY2022 PERIOD ENDING JUNE 30, 2022, JDRF DIRECTLY FUNDED RESEARCH GRANTS AND INDUSTRY AGREEMENTS FOR WHICH $70 MILLION IN RESEARCH GRANT EXPENSE, NET WAS RECOGNIZED ACCORDING TO GAAP AND EXCLUDING $11.8 MILLION OF PROGRAMMATIC RESEARCH INVESTMENTS THAT ARE RECORDED ON THE ORGANIZATION'S BALANCE SHEET. FOR AN EXPANDED DESCRIPTION OF PROGRAM SERVICE ACTIVITIES RELATED TO DIRECT RESEARCH FUNDING, SEE SCHEDULE O.	Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

Field	Value	IRS element (for citing)
Expense	$36,669,581	ExpenseAmt
Desc	RESEARCH SUPPORT - JDRF MAINTAINS AN IN-HOUSE TEAM OF SKILLEDSCIENTIFIC, MEDICAL, POLICY AND GOVERNMENT RELATIONS PROFESSIONALSWHO PLAY A CRITICAL ROLE IN LEADING AND SUPPORTING THE EVALUATIONOF RESEARCH FUNDING OPPORTUNITIES BY JDRF AND INFLUENCING RESEARCHDIRECTION AND THE DISBURSEMENT OF RESEARCH FUNDS FROM OTHERS.THESE PROFESSIONALS ALSO WORK WITH REGULATORY AND POLICY OFFICIALSTO ENSURE THAT RESEARCH CAN PROCEED WITHOUT DELAY AND RESULTS AREUNDERSTOOD BY HEALTHCARE DECISION MAKERS. FOR AN EXPANDEDDESCRIPTION OF PROGRAM SERVICE ACTIVITIES RELATED TO RESEARCHSUPPORT, SEE SCHEDULE O.	Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

Field	Value	IRS element (for citing)
Expense	$13,713,654	ExpenseAmt
Desc	PUBLIC EDUCATION AND OUTREACH - JDRF EDUCATES THE COMMUNITY AND PROVIDES OUTREACH SERVICES TO NEWLY DIAGNOSED CHILDREN AND ADULTS, THEIR FAMILIES, AND OTHERS ABOUT TYPE 1 DIABETES (T1D) AND ITS COMPLICATIONS. FOR AN EXPANDED DESCRIPTION OF PROGRAM SERVICE ACTIVITIES RELATED TO PUBLIC EDUCATION AND OUTREACH, SEE SCHEDULE O.	Desc

Field	Value	IRS element (for citing)
Total Program Service Expenses	$122,535,940	TotalProgramServiceExpensesAmt
Described In Section501c3	Yes (1)	DescribedInSection501c3Ind
Schedule B Required	Yes (1)	ScheduleBRequiredInd
Political Campaign Acty	0	PoliticalCampaignActyInd
Lobbying Activities	Yes (1)	LobbyingActivitiesInd
Subject To Proxy Tax	0	SubjectToProxyTaxInd
Donor Advised Fund	0	DonorAdvisedFundInd
Conservation Easements	0	ConservationEasementsInd
Collections Of Art	0	CollectionsOfArtInd
Credit Counseling	0	CreditCounselingInd
Donor Rstr Or Quasi Endowments	Yes (1)	DonorRstrOrQuasiEndowmentsInd
Report Land Building Equipment	Yes (1)	ReportLandBuildingEquipmentInd
Report Investments Other Sec	0	ReportInvestmentsOtherSecInd
Report Program Related Invst	Yes (1)	ReportProgramRelatedInvstInd
Report Other Assets	0	ReportOtherAssetsInd
Report Other Liabilities	Yes (1)	ReportOtherLiabilitiesInd
Include FIN48 Footnote	Yes (1)	IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt	0	IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt	Yes (1)	ConsolidatedAuditFinclStmtInd
School Operating	0	SchoolOperatingInd
Foreign Office	Yes (1)	ForeignOfficeInd
Foreign Activities	Yes (1)	ForeignActivitiesInd
More Than5000 K To Org	Yes (1)	MoreThan5000KToOrgInd
More Than5000 K To Individuals	0	MoreThan5000KToIndividualsInd
Professional Fundraising	Yes (1)	ProfessionalFundraisingInd
Fundraising Activities	Yes (1)	FundraisingActivitiesInd
Gaming Activities	Yes (1)	GamingActivitiesInd
Operate Hospital	0	OperateHospitalInd
Grants To Organizations	Yes (1)	GrantsToOrganizationsInd
Grants To Individuals	0	GrantsToIndividualsInd
Schedule J Required	Yes (1)	ScheduleJRequiredInd
Tax Exempt Bonds	0	TaxExemptBondsInd
Engaged In Excess Benefit Trans	0	EngagedInExcessBenefitTransInd
PY Excess Benefit Trans	0	PYExcessBenefitTransInd
Loan Outstanding	0	LoanOutstandingInd
Grant To Related Person	0	GrantToRelatedPersonInd
Business Rln With Org Mem	0	BusinessRlnWithOrgMemInd
Business Rln With Fam Mem	Yes (1)	BusinessRlnWithFamMemInd
Business Rln With35 Ctrl Ent	Yes (1)	BusinessRlnWith35CtrlEntInd
Deductible Non Cash Contri	Yes (1)	DeductibleNonCashContriInd
Deductible Art Contribution	0	DeductibleArtContributionInd
Terminate Operations	0	TerminateOperationsInd
Partial Liquidation	0	PartialLiquidationInd
Disregarded Entity	Yes (1)	DisregardedEntityInd
Related Entity	0	RelatedEntityInd
Related Organization Ctrl Ent	0	RelatedOrganizationCtrlEntInd
Transaction With Control Ent	0	TransactionWithControlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org	0	TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp	0	ActivitiesConductedPrtshpInd
Schedule O Required	Yes (1)	ScheduleORequiredInd
IRP Document	227	IRPDocumentCnt
IRP Document W2 G	3	IRPDocumentW2GCnt
Backup Wthld Compliance	Yes (1)	BackupWthldComplianceInd
Employee	496	EmployeeCnt
Employment Tax Returns Filed	Yes (1)	EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit	Yes (1)	UnrelatedBusIncmOverLimitInd
Form990 T Filed	Yes (1)	Form990TFiledInd
Foreign Financial Account	0	ForeignFinancialAccountInd
Prohibited Tax Shelter Trans	0	ProhibitedTaxShelterTransInd
Taxable Party Notification	0	TaxablePartyNotificationInd
Nondeductible Contributions	0	NondeductibleContributionsInd
Quid Pro Quo Contributions	Yes (1)	QuidProQuoContributionsInd
Quid Pro Quo Contri Discl	Yes (1)	QuidProQuoContriDisclInd
Form8282 Property Disposed Of	0	Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct	0	RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct	0	PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services	0	IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt	0	SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc	0	SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VI	Yes (X)	InfoInScheduleOPartVIInd
Governing Body Voting Members	15	GoverningBodyVotingMembersCnt
Independent Voting Member	14	IndependentVotingMemberCnt
Family Or Business Rln	0	FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties	0	DelegationOfMgmtDutiesInd
Change To Org Documents	0	ChangeToOrgDocumentsInd
Material Diversion Or Misuse	0	MaterialDiversionOrMisuseInd
Members Or Stockholders	0	MembersOrStockholdersInd
Election Of Board Members	0	ElectionOfBoardMembersInd
Decisions Subject To Approva	0	DecisionsSubjectToApprovaInd
Minutes Of Governing Body	Yes (1)	MinutesOfGoverningBodyInd
Minutes Of Committees	Yes (1)	MinutesOfCommitteesInd
Officer Mailing Address	0	OfficerMailingAddressInd
Local Chapters	Yes (1)	LocalChaptersInd
Policies Reference Chapters	Yes (1)	PoliciesReferenceChaptersInd
Form990 Provided To Gvrn Body	Yes (1)	Form990ProvidedToGvrnBodyInd
Conflict Of Interest Policy	Yes (1)	ConflictOfInterestPolicyInd
Annual Disclosure Covered Prsn	Yes (1)	AnnualDisclosureCoveredPrsnInd
Regular Monitoring Enfrc	Yes (1)	RegularMonitoringEnfrcInd
Whistleblower Policy	Yes (1)	WhistleblowerPolicyInd
Document Retention Policy	Yes (1)	DocumentRetentionPolicyInd
Compensation Process CEO	Yes (1)	CompensationProcessCEOInd
Compensation Process Other	Yes (1)	CompensationProcessOtherInd
Investment In Joint Venture	Yes (1)	InvestmentInJointVentureInd
Written Policy Or Procedure	Yes (1)	WrittenPolicyOrProcedureInd
States Where Copy Of Return Is Fld	AL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	AK	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	AZ	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	AR	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	CA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	CO	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	CT	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	DE	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	DC	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	FL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	GA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	HI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	ID	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	IL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	IN	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	IA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	KS	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	KY	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	LA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	ME	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MD	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MN	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MS	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MO	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MT	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NE	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NV	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NH	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NJ	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NM	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NY	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NC	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	ND	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OH	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OK	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OR	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	PA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	RI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	SC	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	TN	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	TX	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	UT	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	VT	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	VA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WV	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WY	StatesWhereCopyOfReturnIsFldCd
Own Website	Yes (X)	OwnWebsiteInd
Upon Request	Yes (X)	UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

Field	Value	IRS element (for citing)
Business Name Line1	ROBERT KING	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Phone	8005332873	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	200 VESEY STREET 28TH FLOOR	AddressLine1Txt
City	NEW YORK	CityNm
State Abbreviation	NY	StateAbbreviationCd
ZIP	10281	ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (31 entries)

TitleTitleTxt	Average Hours Per WeekAverageHoursPerWeekRt	Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt	Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd	OfficerOfficerInd	Reportable Comp From OrgReportableCompFromOrgAmt	Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt	Other CompensationOtherCompensationAmt	Key EmployeeKeyEmployeeInd	Highest Compensated EmployeeHighestCompensatedEmployeeInd	Former Ofcr Director TrusteeFormerOfcrDirectorTrusteeInd
JOE LACHER
CHAIR OF THE BOARD	5.00	0.00	Yes (X)	Yes (X)	$0	$0	$0
LISA WALLACK
VICE CHAIR OF THE BOARD	5.00	0.00	Yes (X)	Yes (X)	$0	$0	$0
MICHAEL ALTER
CHAIR, FUNDING COMMITTEE	5.00	0.00	Yes (X)		$0	$0	$0
GRANT BEARD
CHAIR, AUDIT & RISK COMMITTEE	5.00	0.00	Yes (X)		$0	$0	$0
ELIZABETH CASWELL
BOARD MEMBER	5.00	0.00	Yes (X)		$0	$0	$0
STEVEN DAVIS
CHAIR NOMINATING & GOV COMMITTEE	5.00	0.00	Yes (X)		$0	$0	$0
CLAUDIA GRAHAM PHD
BOARD MEMBER	3.00	0.00	Yes (X)		$0	$0	$0
PAUL HEATH
CHAIR, ADVOCACY & IMPACT COMMITTEE	5.00	0.00	Yes (X)		$0	$0	$0
KAREN JORDAN
CHAIR, RESEARCH COMMITTEE	5.00	0.00	Yes (X)		$0	$0	$0
JEFF PLUMER
CHAIR, TALENT & COMP. COMMITTEE	5.00	0.00	Yes (X)		$0	$0	$0
JENNIFER SCHNEIDER MD
BOARD MEMBER	3.00	0.00	Yes (X)		$0	$0	$0
CHRISTOPHER TURNER
CHAIR, FINANCE & INVEST. COMM	5.00	0.00	Yes (X)		$0	$0	$0
MATT VAREY
BOARD MEMBER	3.00	0.00	Yes (X)		$0	$0	$0
DRAYTON VIRKLER
BOARD MEMBER	3.00	0.00	Yes (X)		$0	$0	$0
KAREY L WITTY
BOARD MEMBER	3.00	0.00	Yes (X)		$0	$0	$0
AARON KOWALSKI PHD
CHIEF EXECUTIVE OFFICER	50.00	0.00		Yes (X)	$751,382	$0	$71,994
TIMOTHY DOYLE
COO/PRESIDENT/ASST TREAS (BEG 12/21)	50.00	0.00		Yes (X)	$544,030	$0	$56,100
ANNE GEHRING
CONTRACT CFO (BEG 5/21, END 10/21)	50.00	0.00		Yes (X)	$174,363	$0	$0
ROBERT KING
CFAO/TREASURER (BEG 10/21)	50.00	0.00		Yes (X)	$81,324	$0	$5,975
TROY LINDLOFF
CDO/ASST. TREASURER (END 11/21)	50.00	0.00		Yes (X)	$500,110	$0	$17,699
JAMES MCDONALD
BOARD LIAISON/SECRETARY	50.00	0.00		Yes (X)	$125,218	$0	$6,797
SYDNEY YOVIC
CHIEF OF STAFF/ASSISTANT SECRETARY	50.00	0.00		Yes (X)	$259,812	$0	$44,411
SANJOY DUTTA PHD
CHIEF SCIENTIFIC OFFICER	50.00	0.00			$345,769	$0	$20,465	Yes (X)
STEVEN ST PETER
MANAGING DIRECTOR, T1D FUND	50.00	0.00			$712,891	$0	$38,127	Yes (X)
HELEN ELLIAS
MANAGING DIRECTOR, T1D FUND	50.00	0.00			$529,668	$0	$63,779	Yes (X)
CRAIG ROBERTSON
VP, FIELD DEVELOPMENT	50.00	0.00			$310,533	$0	$31,277		Yes (X)
CYNTHIA RICE
CHIEF MISSION OFFICER	50.00	0.00			$347,838	$0	$39,881		Yes (X)
GILLIAN GREEN
VP LEADERSHIP GIVING	50.00	0.00			$303,511	$0	$47,676		Yes (X)
YURY KUKUSHKIN
MANAGING DIRECTOR, T1D FUND	50.00	0.00			$310,631	$0	$15,183		Yes (X)
SRINIVAS MISHRA
CHIEF TECH OFFICER (END 8/21)	50.00	0.00			$245,705	$0	$28,010		Yes (X)
JOANNE MARTZ
CFO/TREASURER (END 5/21)	50.00	0.00			$348,691	$0	$24,485			Yes (X)

Field	Value	IRS element (for citing)
Total Reportable Comp From Org	$5,891,476	TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org	$0	TotReportableCompRltdOrgAmt
Total Other Compensation	$511,859	TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K	151	IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed	Yes (1)	FormerOfcrEmployeesListedInd
Total Comp Greater Than150 K	Yes (1)	TotalCompGreaterThan150KInd
Compensation From Other Srcs	0	CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1Txt	CityContractorAddress/USAddress/CityNm	State AbbreviationContractorAddress/USAddress/StateAbbreviationCd	ZIPContractorAddress/USAddress/ZIPCd	ServicesServicesDesc	CompensationCompensationAmt
INNOVATION CLOUD LLC
356 OSWEGO CT	WEST NEW YORK	NJ	07093	IT CONSULTING	$2,476,956
THE PURSUANT GROUP
15660 DALLAS PKWY SUITE 1000	DALLAS	TX	75248	FUNDRAISING AND MARKETING	$1,681,088
KAVYOS CONSULTING INC
485 C ROUTE 1 SOUTH SUITE 320	ISELIN	NJ	08830	IT CONSULTING	$1,223,483
BLACKBAUD INC
65 FAIRCHILD STREET	CHARLESTON	SC	29492	SOFTWARE SERVICES	$1,199,682
BLUE STATE DIGITAL
41 FLATBUSH AVENUE	BROOKLYN	NY	11217	FUNDRAISING AND MARKETING	$1,162,384

Field	Value	IRS element (for citing)
Cntrct Rcvd Greater Than100 K	57	CntrctRcvdGreaterThan100KCnt
Federated Campaigns	$2,943,084	FederatedCampaignsAmt
Fundraising	$99,817,013	FundraisingAmt
All Other Contributions	$102,316,395	AllOtherContributionsAmt
Noncash Contributions	$5,611,770	NoncashContributionsAmt
Total Contributions	$205,076,492	TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp

Field	Value	IRS element (for citing)
Desc	PROGRAM RELATED INVEST	Desc
Business	541714	BusinessCd
Total Revenue Column	$20,503,582	TotalRevenueColumnAmt
Exclusion	$20,503,582	ExclusionAmt

Field	Value	IRS element (for citing)
Total Program Service Revenue	$20,503,582	TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$2,775,930	TotalRevenueColumnAmt
Unrelated Business Revenue	$96,472	UnrelatedBusinessRevenueAmt
Exclusion	$2,679,458	ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

Field	Value	IRS element (for citing)
Securities	$131,868,601	SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

Field	Value	IRS element (for citing)
Securities	$124,360,712	SecuritiesAmt

Gain Or Loss GainOrLossGrp

Field	Value	IRS element (for citing)
Securities	$7,507,889	SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$7,507,889	TotalRevenueColumnAmt
Exclusion	$7,507,889	ExclusionAmt

Field	Value	IRS element (for citing)
Fundraising Gross Income	$16,742,873	FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event	$99,817,013	ContriRptFundraisingEventAmt
Fundraising Direct Expenses	$16,742,873	FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt

Field	Value	IRS element (for citing)
Gaming Gross Income	$738,140	GamingGrossIncomeAmt
Gaming Direct Expenses	$10,000	GamingDirectExpensesAmt

Net Income From Gaming NetIncomeFromGamingGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$728,140	TotalRevenueColumnAmt
Exclusion	$728,140	ExclusionAmt

Other Revenue Misc OtherRevenueMiscGrp (2 entries)

DescDesc	BusinessBusinessCd	Total Revenue ColumnTotalRevenueColumnAmt	ExclusionExclusionAmt
GRANT REFUNDS & ADJUST	813212	$1,617,037	$1,617,037
MISC REVENUE	900099	$386,435	$386,435

Field	Value	IRS element (for citing)
Other Revenue Total	$2,003,472	OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$238,595,505	TotalRevenueColumnAmt
Related Or Exempt Func Income	$0	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$96,472	UnrelatedBusinessRevenueAmt
Exclusion	$33,422,541	ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

Field	Value	IRS element (for citing)
Total	$49,414,448	TotalAmt
Program Services	$49,414,448	ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

Field	Value	IRS element (for citing)
Total	$22,738,257	TotalAmt
Program Services	$22,738,257	ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

Field	Value	IRS element (for citing)
Total	$4,545,719	TotalAmt
Program Services	$2,956,133	ProgramServicesAmt
Management And General	$695,654	ManagementAndGeneralAmt
Fundraising	$893,932	FundraisingAmt

Comp Disqual Persons CompDisqualPersonsGrp

Field	Value	IRS element (for citing)
Total	$60,386	TotalAmt
Program Services	$60,386	ProgramServicesAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

Field	Value	IRS element (for citing)
Total	$42,629,011	TotalAmt
Program Services	$24,403,950	ProgramServicesAmt
Management And General	$5,239,227	ManagementAndGeneralAmt
Fundraising	$12,985,834	FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

Field	Value	IRS element (for citing)
Total	$1,186,454	TotalAmt
Program Services	$691,504	ProgramServicesAmt
Management And General	$135,454	ManagementAndGeneralAmt
Fundraising	$359,496	FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

Field	Value	IRS element (for citing)
Total	$5,977,931	TotalAmt
Program Services	$3,452,490	ProgramServicesAmt
Management And General	$673,880	ManagementAndGeneralAmt
Fundraising	$1,851,561	FundraisingAmt

Payroll Taxes PayrollTaxesGrp

Field	Value	IRS element (for citing)
Total	$2,746,557	TotalAmt
Program Services	$1,586,689	ProgramServicesAmt
Management And General	$350,579	ManagementAndGeneralAmt
Fundraising	$809,289	FundraisingAmt

Fees For Services Legal FeesForServicesLegalGrp

Field	Value	IRS element (for citing)
Total	$470,275	TotalAmt
Program Services	$307,693	ProgramServicesAmt
Management And General	$43,336	ManagementAndGeneralAmt
Fundraising	$119,246	FundraisingAmt

Fees For Services Accounting FeesForServicesAccountingGrp

Field	Value	IRS element (for citing)
Total	$217,925	TotalAmt
Management And General	$217,925	ManagementAndGeneralAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

Field	Value	IRS element (for citing)
Total	$127,123	TotalAmt
Program Services	$127,123	ProgramServicesAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

Field	Value	IRS element (for citing)
Total	$1,388,063	TotalAmt
Fundraising	$1,388,063	FundraisingAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

Field	Value	IRS element (for citing)
Total	$440,890	TotalAmt
Management And General	$440,890	ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

Field	Value	IRS element (for citing)
Total	$2,743,072	TotalAmt
Program Services	$937,007	ProgramServicesAmt
Management And General	$916,000	ManagementAndGeneralAmt
Fundraising	$890,065	FundraisingAmt

Advertising AdvertisingGrp

Field	Value	IRS element (for citing)
Total	$2,026,369	TotalAmt
Program Services	$850,270	ProgramServicesAmt
Management And General	$129,624	ManagementAndGeneralAmt
Fundraising	$1,046,475	FundraisingAmt

Office Expenses OfficeExpensesGrp

Field	Value	IRS element (for citing)
Total	$767,097	TotalAmt
Program Services	$456,647	ProgramServicesAmt
Management And General	$83,796	ManagementAndGeneralAmt
Fundraising	$226,654	FundraisingAmt

Information Technology InformationTechnologyGrp

Field	Value	IRS element (for citing)
Total	$5,936,467	TotalAmt
Program Services	$3,461,593	ProgramServicesAmt
Management And General	$684,689	ManagementAndGeneralAmt
Fundraising	$1,790,185	FundraisingAmt

Occupancy OccupancyGrp

Field	Value	IRS element (for citing)
Total	$4,913,003	TotalAmt
Program Services	$2,830,110	ProgramServicesAmt
Management And General	$574,400	ManagementAndGeneralAmt
Fundraising	$1,508,493	FundraisingAmt

Travel TravelGrp

Field	Value	IRS element (for citing)
Total	$839,275	TotalAmt
Program Services	$453,886	ProgramServicesAmt
Management And General	$74,842	ManagementAndGeneralAmt
Fundraising	$310,547	FundraisingAmt

Conferences Meetings ConferencesMeetingsGrp

Field	Value	IRS element (for citing)
Total	$498,654	TotalAmt
Program Services	$195,785	ProgramServicesAmt
Management And General	$58,077	ManagementAndGeneralAmt
Fundraising	$244,792	FundraisingAmt

Interest InterestGrp

Field	Value	IRS element (for citing)
Total	$2,556	TotalAmt
Program Services	$1,427	ProgramServicesAmt
Management And General	$322	ManagementAndGeneralAmt
Fundraising	$807	FundraisingAmt

Depreciation Depletion DepreciationDepletionGrp

Field	Value	IRS element (for citing)
Total	$6,330,959	TotalAmt
Program Services	$3,652,269	ProgramServicesAmt
Management And General	$758,536	ManagementAndGeneralAmt
Fundraising	$1,920,154	FundraisingAmt

Insurance InsuranceGrp

Field	Value	IRS element (for citing)
Total	$556,782	TotalAmt
Program Services	$227,239	ProgramServicesAmt
Management And General	$189,257	ManagementAndGeneralAmt
Fundraising	$140,286	FundraisingAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDesc	TotalTotalAmt	Program ServicesProgramServicesAmt	Management And GeneralManagementAndGeneralAmt	FundraisingFundraisingAmt
OUTREACH EXPENSES	$4,161,874	$3,226,293	$637,086	$298,495
FUNDRAISING POSTAGE & P	$1,278,245			$1,278,245
DUES, FEES, & SUB	$665,413	$366,540	$136,613	$162,260
OTHER	$226,394	$138,201	$25,635	$62,558

Total Functional Expenses TotalFunctionalExpensesGrp

Field	Value	IRS element (for citing)
Total	$162,889,199	TotalAmt
Program Services	$122,535,940	ProgramServicesAmt
Management And General	$12,065,822	ManagementAndGeneralAmt
Fundraising	$28,287,437	FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

Field	Value	IRS element (for citing)
BOY	$26,785,629	BOYAmt
EOY	$34,312,094	EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

Field	Value	IRS element (for citing)
BOY	$19,599,908	BOYAmt
EOY	$4,006,288	EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$51,322,172	BOYAmt
EOY	$56,535,885	EOYAmt

Accounts Receivable AccountsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$3,785,572	BOYAmt
EOY	$2,438,959	EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

Field	Value	IRS element (for citing)
BOY	$3,450,000	BOYAmt
EOY	$2,218,711	EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

Field	Value	IRS element (for citing)
BOY	$6,454,865	BOYAmt
EOY	$15,358,433	EOYAmt

Field	Value	IRS element (for citing)
Land Bldg Equip Cost Or Other Bss	$25,368,692	LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec	$14,797,623	LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

Field	Value	IRS element (for citing)
BOY	$11,818,148	BOYAmt
EOY	$10,571,069	EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

Field	Value	IRS element (for citing)
BOY	$174,011,783	BOYAmt
EOY	$212,935,519	EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

Field	Value	IRS element (for citing)
BOY	$748,528	BOYAmt
EOY	$533,309	EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

Field	Value	IRS element (for citing)
BOY	$63,338,621	BOYAmt
EOY	$50,551,398	EOYAmt

Intangible Assets IntangibleAssetsGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt

Total Assets TotalAssetsGrp

Field	Value	IRS element (for citing)
BOY	$361,315,226	BOYAmt
EOY	$389,461,665	EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

Field	Value	IRS element (for citing)
BOY	$23,190,389	BOYAmt
EOY	$17,575,122	EOYAmt

Grants Payable GrantsPayableGrp

Field	Value	IRS element (for citing)
BOY	$61,750,136	BOYAmt
EOY	$69,409,827	EOYAmt

Deferred Revenue DeferredRevenueGrp

Field	Value	IRS element (for citing)
BOY	$13,236,673	BOYAmt
EOY	$5,150,523	EOYAmt

Other Liabilities OtherLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$2,584,103	BOYAmt
EOY	$2,415,955	EOYAmt

Total Liabilities TotalLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$100,761,301	BOYAmt
EOY	$94,551,427	EOYAmt

Field	Value	IRS element (for citing)
Organization Follows FASB117	Yes (X)	OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$193,001,095	BOYAmt
EOY	$229,545,554	EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$67,552,830	BOYAmt
EOY	$65,364,684	EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$260,553,925	BOYAmt
EOY	$294,910,238	EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$361,315,226	BOYAmt
EOY	$389,461,665	EOYAmt

Field	Value	IRS element (for citing)
Reconcilation Revenue Expnss	$75,706,306	ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst	-$41,349,993	NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets	$0	OtherChangesInNetAssetsAmt
Method Of Accounting Accrual	Yes (X)	MethodOfAccountingAccrualInd
Accountant Compile Or Review	0	AccountantCompileOrReviewInd
FS Audited	Yes (1)	FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

Field	Value	IRS element (for citing)
Consolidated Basis Fincl Stmt	Yes (X)	ConsolidatedBasisFinclStmtInd

Field	Value	IRS element (for citing)
Audit Committee	Yes (1)	AuditCommitteeInd
Federal Grant Audit Required	0	FederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

Field	Value	IRS element (for citing)
Public Organization170	Yes (X)	PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$219,968,105	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$215,659,011	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$194,074,339	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$190,647,071	CurrentTaxYearMinus1YearAmt
Current Tax Year	$203,302,047	CurrentTaxYearAmt
Total	$1,023,650,573	TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$219,968,105	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$215,659,011	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$194,074,339	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$190,647,071	CurrentTaxYearMinus1YearAmt
Current Tax Year	$203,302,047	CurrentTaxYearAmt
Total	$1,023,650,573	TotalAmt

Field	Value	IRS element (for citing)
Substantial Contributors Tot	$716,203	SubstantialContributorsTotAmt
Public Support Total170	$1,022,934,370	PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$1,309,523	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$2,439,225	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$2,918,738	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$2,297,884	CurrentTaxYearMinus1YearAmt
Current Tax Year	$2,679,851	CurrentTaxYearAmt
Total	$11,645,221	TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$138,747	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$186,965	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$29,579	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$58,494	CurrentTaxYearMinus1YearAmt
Current Tax Year	$96,079	CurrentTaxYearAmt
Total	$509,864	TotalAmt

Other Income170 OtherIncome170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$1,793,044	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$2,313,482	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$1,671,720	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$3,345,522	CurrentTaxYearMinus1YearAmt
Current Tax Year	$22,507,054	CurrentTaxYearAmt
Total	$31,630,822	TotalAmt

Field	Value	IRS element (for citing)
Total Support	$1,067,436,480	TotalSupportAmt
Public Support CY170	0.95830	PublicSupportCY170Pct
Public Support PY170	0.98140	PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170	Yes (X)	ThirtyThrPctSuprtTestsCY170Ind

Form990 Schedule A Part VI Form990ScheduleAPartVIGrp

Field	Value	IRS element (for citing)
Form And Line Reference	SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME:	FormAndLineReferenceDesc
Explanation	OTHER INCOME - 2017 AMOUNT: $ 1,793,044. 2018 AMOUNT: $ 2,313,482. 2019 AMOUNT: $ 1,671,720. 2020 AMOUNT: $ 3,345,522. 2021 AMOUNT: $ 22,507,054.	ExplanationTxt

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

Field	Value	IRS element (for citing)
Contributor	RESTRICTED	ContributorNum

Contributor Business Name ContributorBusinessName

Field	Value	IRS element (for citing)
Business Name Line1	RESTRICTED	BusinessNameLine1

Contributor US Address ContributorUSAddress

Field	Value	IRS element (for citing)
Address Line1	RESTRICTED	AddressLine1
Address Line2	RESTRICTED	AddressLine2
City	RESTRICTED	City
State	RESTRICTED	State
ZIP Code	RESTRICTED	ZIPCode

Field	Value	IRS element (for citing)
Total Contributions	RESTRICTED	TotalContributionsAmt

Schedule C IRS990ScheduleC

Field	Value	IRS element (for citing)
Volunteers	0	VolunteersInd
Paid Staff Or Management	0	PaidStaffOrManagementInd
Media Advertisements	0	MediaAdvertisementsInd
Mailings Members	Yes (1)	MailingsMembersInd
Mailings Members	$11,440	MailingsMembersAmt
Publications Or Broadcast	0	PublicationsOrBroadcastInd
Grants Other Organizations	Yes (1)	GrantsOtherOrganizationsInd
Grants Other Organizations	$3,990	GrantsOtherOrganizationsAmt
Direct Contact Legislators	Yes (1)	DirectContactLegislatorsInd
Direct Contact Legislators	$215,517	DirectContactLegislatorsAmt
Rallies Demonstrations	0	RalliesDemonstrationsInd
Other Activities	0	OtherActivitiesInd
Total Lobbying Expenditures	$230,947	TotalLobbyingExpendituresAmt
Not Described Section501c3	0	NotDescribedSection501c3Ind

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	PART II-B, LINE 1:	FormAndLineReferenceDesc
Explanation	GENERAL STATEMENT OF ACTIVITIES JDRF IS THE LEADING GLOBAL ORGANIZATION FUNDING TYPE 1 DIABETES (T1D) RESEARCH, FOCUSED ON CURING T1D AND IMPROVING LIVES. JDRF'S ADVOCACY INCLUDES LOBBYING ACTIVITY TO ENSURE CONGRESS CONTINUES TO INVEST IN CRITICALLY IMPORTANT MEDICAL RESEARCH AND PUTS IN PLACE POLICIES TO ADVANCE DEVELOPMENT AND ACCESS TO THERAPIES TO CURE T1D AND HELP PEOPLE STAY AS HEALTHY AS POSSIBLE UNTIL THAT DAY. JDRF HAS BEEN INSTRUMENTAL IN SECURING THE RENEWAL OF THE SPECIAL DIABETES PROGRAM, WHICH PROVIDES $150M ANNUALLY FOR T1D RESEARCH AT THE NATIONAL INSTITUTES OF HEALTH. JDRF STAFF AND VOLUNTEERS COMMUNICATE WITH GOVERNMENT OFFICIALS THROUGH EMAIL, PHONE CALLS, AND MEETINGS, TO EDUCATE THEM ON ISSUES AND ENCOURAGE THE ADVANCEMENT OF LEGISLATION.	ExplanationTxt

Schedule D IRS990ScheduleD

CY Endwmt Fund CYEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$8,911,983	BeginningYearBalanceAmt
Contributions	$25,000	ContributionsAmt
Investment Earnings Or Losses	-$1,144,983	InvestmentEarningsOrLossesAmt
Other Expenditures	$207,917	OtherExpendituresAmt
End Year Balance	$7,584,083	EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$7,709,169	BeginningYearBalanceAmt
Investment Earnings Or Losses	$2,111,094	InvestmentEarningsOrLossesAmt
Other Expenditures	$908,280	OtherExpendituresAmt
End Year Balance	$8,911,983	EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$7,887,833	BeginningYearBalanceAmt
Contributions	-$140,727	ContributionsAmt
Investment Earnings Or Losses	$33,086	InvestmentEarningsOrLossesAmt
Other Expenditures	$71,023	OtherExpendituresAmt
End Year Balance	$7,709,169	EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$7,567,601	BeginningYearBalanceAmt
Contributions	$221,441	ContributionsAmt
Investment Earnings Or Losses	$102,034	InvestmentEarningsOrLossesAmt
Other Expenditures	$3,243	OtherExpendituresAmt
End Year Balance	$7,887,833	EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$7,341,367	BeginningYearBalanceAmt
Investment Earnings Or Losses	$268,304	InvestmentEarningsOrLossesAmt
Other Expenditures	$42,070	OtherExpendituresAmt
End Year Balance	$7,567,601	EndYearBalanceAmt

Field	Value	IRS element (for citing)
Board Designated Balance EOY	0.00000	BoardDesignatedBalanceEOYPct
Prmnnt Endowment Balance EOY	1.00000	PrmnntEndowmentBalanceEOYPct
Term Endowment Balance EOY	0.00000	TermEndowmentBalanceEOYPct
Endowments Held Unrelated Org	0	EndowmentsHeldUnrelatedOrgInd
Endowments Held Related Org	0	EndowmentsHeldRelatedOrgInd

Leasehold Improvements LeaseholdImprovementsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$1,009,931	OtherCostOrOtherBasisAmt
Depreciation	$203,913	DepreciationAmt
Book Value	$806,018	BookValueAmt

Equipment EquipmentGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$24,358,761	OtherCostOrOtherBasisAmt
Depreciation	$14,593,710	DepreciationAmt
Book Value	$9,765,051	BookValueAmt

Field	Value	IRS element (for citing)
Total Book Value Land Buildings	$10,571,069	TotalBookValueLandBuildingsAmt

Invst Program Related Org InvstProgramRelatedOrgGrp

Field	Value	IRS element (for citing)
Desc	T1D FUND PROGRAM RELATED INVESTMENT	Desc
Book Value	$50,551,398	BookValueAmt
Method Valuation	F	MethodValuationCd

Field	Value	IRS element (for citing)
Total Book Value Program Rltd	$50,551,398	TotalBookValueProgramRltdAmt

Other Liabilities Org OtherLiabilitiesOrgGrp

Field	Value	IRS element (for citing)
Desc	SPLIT INTEREST CHARITABLE RMDR TRUST	Desc
Amt	$2,415,955	Amt

Field	Value	IRS element (for citing)
Total Liability	$2,415,955	TotalLiabilityAmt
Footnote Text	Yes (X)	FootnoteTextInd
Total Rev Etc Audited Fincl Stmt	$195,729,918	TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst	-$41,349,993	NetUnrealizedGainsInvstAmt
Donated Services And Use Fclts	$542,333	DonatedServicesAndUseFcltsAmt
Recoveries Prior Year Grants	-$1,617,037	RecoveriesPriorYearGrantsAmt
Revenue Not Reported	-$42,424,697	RevenueNotReportedAmt
Revenue Subtotal	$238,154,615	RevenueSubtotalAmt
Investment Expenses Not Incld	$440,890	InvestmentExpensesNotIncldAmt
Revenue Not Reported Fincl Stmt	$440,890	RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990	$238,595,505	TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt	$161,373,605	TotExpnsEtcAuditedFinclStmtAmt
Donated Services Use Fclts	$542,333	DonatedServicesUseFcltsAmt
Prior Year Adjustments	-$1,617,037	PriorYearAdjustmentsAmt
Expenses Not Reported	-$1,074,704	ExpensesNotReportedAmt
Expenses Subtotal	$162,448,309	ExpensesSubtotalAmt
Investment Expenses Not Incld2	$440,890	InvestmentExpensesNotIncld2Amt
Expenses Not Rpt Fincl Stmt	$440,890	ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990	$162,889,199	TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDesc

ExplanationExplanationTxt

PART V, LINE 4:

ORGANIZATION'S ENDOWMENT FUNDS THE ORGANIZATION UTILIZES EARNINGS ON ENDOWMENT FUNDS IN THE MANNER SPECIFIED BY THE DONOR AND/OR FOR SUPPORTING THE ORGANIZATION'S GENERAL EXEMPT PURPOSE.

PART X, LINE 2:

UNCERTAIN TAX POSITIONS JDRF IS A NOT-FOR-PROFIT ORGANIZATION EXEMPT FROM FEDERAL INCOME TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE AND IS ORGANIZED UNDER THE LAWS OF THE COMMONWEALTH OF PENNSYLVANIA. THE EFFECT OF INCOME TAX POSITIONS IS RECOGNIZED ONLY IF THE POSITIONS ARE MORE LIKELY THAN NOT OF BEING SUSTAINED. INCOME GENERATED FROM ACTIVITIES UNRELATED TO JDRF'S EXEMPT PURPOSE IS SUBJECT TO TAX UNDER INTERNAL REVENUE CODE SECTION 511. UNRELATED BUSINESS INCOME TAX LIABILITY WAS INSIGNIFICANT FOR THE YEARS ENDING JUNE 30, 2022 AND 2021.

Schedule F IRS990ScheduleF

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (1)	GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (8 entries)

RegionRegionTxt	Type Of Activities ConductedTypeOfActivitiesConductedTxt	Specific Services ProvidedSpecificServicesProvidedTxt	Region Total ExpendituresRegionTotalExpendituresAmt	EmployeeEmployeeCnt
EAST ASIA AND THE PACIFIC	GRANTMAKING	RESEARCH GRANTS	$5,016,705
NORTH AMERICA	GRANTMAKING	RESEARCH GRANTS	$3,825,650
EUROPE	GRANTMAKING	RESEARCH GRANTS	$11,420,906
MIDDLE EAST AND NORTH AFRICA	GRANTMAKING	RESEARCH GRANTS	$2,274,996
SOUTH ASIA	GRANTMAKING	RESEARCH GRANTS	$200,000
EUROPE	PROGRAM SERVICES	RESEARCH SUPPORT	$294,361	2
EUROPE	INVESTMENTS	INVESTMENTS	$3,431,835
NORTH AMERICA	INVESTMENTS	INVESTMENTS	$3,020,423

Field	Value	IRS element (for citing)
Subtotal Offices	0	SubtotalOfficesCnt
Subtotal Employees	2	SubtotalEmployeesCnt
Continuation Total Office	0	ContinuationTotalOfficeCnt
Continuation Total Employee	0	ContinuationTotalEmployeeCnt
Total Office	0	TotalOfficeCnt
Total Employee	2	TotalEmployeeCnt
Subtotal Spent	$29,484,876	SubtotalSpentAmt
Continuation Spent	$0	ContinuationSpentAmt
Total Spent	$29,484,876	TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (61 entries)

RegionRegionTxt	Purpose Of GrantPurposeOfGrantTxt	Cash GrantCashGrantAmt	Manner Of Cash DisbursementMannerOfCashDisbursementTxt	Non Cash AssistanceNonCashAssistanceAmt	Description Of Non Cash AsstDescriptionOfNonCashAsstTxt	Valuation Method UsedValuationMethodUsedDesc
EUROPE (INCLUDING ICELAND AND GREENLAND)	METABOLIC CONTROL	$81,635	CHECK/WIRE TRANSFER	$0	N/A	N/A
NORTH AMERICA	BETA CELL REPLACEMENT	$50,000	CHECK/WIRE TRANSFER	$0	N/A	N/A
SOUTH ASIA	METABOLIC CONTROL	$200,000	CHECK/WIRE TRANSFER	$0	N/A	N/A
EUROPE (INCLUDING ICELAND AND GREENLAND)	IMMUNOTHERAPIES	$917,181	CHECK/WIRE TRANSFER	$0	N/A	N/A
NORTH AMERICA	PREVENTION	$297,815	CHECK/WIRE TRANSFER	$0	N/A	N/A
EAST ASIA AND THE PACIFIC	MISSION	$800,000	CHECK/WIRE TRANSFER	$0	N/A	N/A
EUROPE (INCLUDING ICELAND AND GREENLAND)	TRANSPORTFOLIO	$56,330	CHECK/WIRE TRANSFER	$0	N/A	N/A
EUROPE (INCLUDING ICELAND AND GREENLAND)	TRANSPORTFOLIO	$94,418	CHECK/WIRE TRANSFER	$0	N/A	N/A
EAST ASIA AND THE PACIFIC	IMMUNOTHERAPIES	$109,278	CHECK/WIRE TRANSFER	$0	N/A	N/A
EUROPE (INCLUDING ICELAND AND GREENLAND)	IMMUNOTHERAPIES	$366,430	CHECK/WIRE TRANSFER	$0	N/A	N/A
NORTH AMERICA	BETA CELL REGENERATION	$325,000	CHECK/WIRE TRANSFER	$0	N/A	N/A
MIDDLE EAST AND NORTH AFRICA	COMPLICATIONS	$360,000	CHECK/WIRE TRANSFER	$0	N/A	N/A
EUROPE (INCLUDING ICELAND AND GREENLAND)	IMMUNOTHERAPIES	$149,963	CHECK/WIRE TRANSFER	$0	N/A	N/A
NORTH AMERICA	METABOLIC CONTROL	$100,967	CHECK/WIRE TRANSFER	$0	N/A	N/A
EUROPE (INCLUDING ICELAND AND GREENLAND)	IMMUNOTHERAPIES	$218,660	CHECK/WIRE TRANSFER	$0	N/A	N/A
EUROPE (INCLUDING ICELAND AND GREENLAND)	IMMUNOTHERAPIES	$126,500	CHECK/WIRE TRANSFER	$0	N/A	N/A
EUROPE (INCLUDING ICELAND AND GREENLAND)	BETA CELL REGENERATION	$499,448	CHECK/WIRE TRANSFER	$0	N/A	N/A
EUROPE (INCLUDING ICELAND AND GREENLAND)	TRANSPORTFOLIO	$465,000	CHECK/WIRE TRANSFER	$0	N/A	N/A
MIDDLE EAST AND NORTH AFRICA	TRANSPORTFOLIO	$833,060	CHECK/WIRE TRANSFER	$0	N/A	N/A
EUROPE (INCLUDING ICELAND AND GREENLAND)	METABOLIC CONTROL	$2,024,922	CHECK/WIRE TRANSFER	$0	N/A	N/A
EUROPE (INCLUDING ICELAND AND GREENLAND)	IMMUNOTHERAPIES	$609,520	CHECK/WIRE TRANSFER	$0	N/A	N/A
EUROPE (INCLUDING ICELAND AND GREENLAND)	PREVENTION	$51,477	CHECK/WIRE TRANSFER	$0	N/A	N/A
EUROPE (INCLUDING ICELAND AND GREENLAND)	METABOLIC CONTROL	$100,000	CHECK/WIRE TRANSFER	$0	N/A	N/A
NORTH AMERICA	ARTIFICIAL PANCREAS	$336,087	CHECK/WIRE TRANSFER	$0	N/A	N/A
EUROPE (INCLUDING ICELAND AND GREENLAND)	BETA CELL REPLACEMENT	$54,419	CHECK/WIRE TRANSFER	$0	N/A	N/A
EUROPE (INCLUDING ICELAND AND GREENLAND)	IMMUNOTHERAPIES	$99,928	CHECK/WIRE TRANSFER	$0	N/A	N/A
EAST ASIA AND THE PACIFIC	IMMUNOTHERAPIES	$300,000	CHECK/WIRE TRANSFER	$0	N/A	N/A
EAST ASIA AND THE PACIFIC	BETA CELL REGENERATION	$109,919	CHECK/WIRE TRANSFER	$0	N/A	N/A
EAST ASIA AND THE PACIFIC	IMMUNOTHERAPIES	$100,000	CHECK/WIRE TRANSFER	$0	N/A	N/A
EUROPE (INCLUDING ICELAND AND GREENLAND)	PSYCHOSOCIAL	$574,929	CHECK/WIRE TRANSFER	$0	N/A	N/A
EUROPE (INCLUDING ICELAND AND GREENLAND)	PREVENTION	$424,616	CHECK/WIRE TRANSFER	$0	N/A	N/A
MIDDLE EAST AND NORTH AFRICA	ARTIFICIAL PANCREAS	$156,936	CHECK/WIRE TRANSFER	$0	N/A	N/A
EAST ASIA AND THE PACIFIC	BETA CELL REPLACEMENT	$95,100	CHECK/WIRE TRANSFER	$0	N/A	N/A
MIDDLE EAST AND NORTH AFRICA	PREVENTION	$775,000	CHECK/WIRE TRANSFER	$0	N/A	N/A
NORTH AMERICA	BETA CELL REPLACEMENT	$181,160	CHECK/WIRE TRANSFER	$0	N/A	N/A
MIDDLE EAST AND NORTH AFRICA	PREVENTION	$150,000	CHECK/WIRE TRANSFER	$0	N/A	N/A
NORTH AMERICA	BETA CELL REPLACEMENT	$374,927	CHECK/WIRE TRANSFER	$0	N/A	N/A
EAST ASIA AND THE PACIFIC	IMMUNOTHERAPIES	$1,635,568	CHECK/WIRE TRANSFER	$0	N/A	N/A
EUROPE (INCLUDING ICELAND AND GREENLAND)	PREVENTION	$162,520	CHECK/WIRE TRANSFER	$0	N/A	N/A
NORTH AMERICA	BETA CELL REPLACEMENT	$410,000	CHECK/WIRE TRANSFER	$0	N/A	N/A
NORTH AMERICA	BETA CELL REPLACEMENT	$497,585	CHECK/WIRE TRANSFER	$0	N/A	N/A
NORTH AMERICA	PSYCHOSOCIAL	$566,484	CHECK/WIRE TRANSFER	$0	N/A	N/A
EAST ASIA AND THE PACIFIC	COMPLICATIONS	$499,999	CHECK/WIRE TRANSFER	$0	N/A	N/A
EAST ASIA AND THE PACIFIC	PREVENTION	$38,837	CHECK/WIRE TRANSFER	$0	N/A	N/A
EUROPE (INCLUDING ICELAND AND GREENLAND)	BETA CELL REPLACEMENT	$647,599	CHECK/WIRE TRANSFER	$0	N/A	N/A
EUROPE (INCLUDING ICELAND AND GREENLAND)	BETA CELL REGENERATION	$349,264	CHECK/WIRE TRANSFER	$0	N/A	N/A
EUROPE (INCLUDING ICELAND AND GREENLAND)	COMPLICATIONS	$117,473	CHECK/WIRE TRANSFER	$0	N/A	N/A
NORTH AMERICA	BETA CELL REPLACEMENT	$262,535	CHECK/WIRE TRANSFER	$0	N/A	N/A
EUROPE (INCLUDING ICELAND AND GREENLAND)	COMPLICATIONS	$472,642	CHECK/WIRE TRANSFER	$0	N/A	N/A
EUROPE (INCLUDING ICELAND AND GREENLAND)	PREVENTION	$1,012,196	CHECK/WIRE TRANSFER	$0	N/A	N/A
EUROPE (INCLUDING ICELAND AND GREENLAND)	METABOLIC CONTROL	$200,816	CHECK/WIRE TRANSFER	$0	N/A	N/A
EUROPE (INCLUDING ICELAND AND GREENLAND)	IMMUNOTHERAPIES	$70,000	CHECK/WIRE TRANSFER	$0	N/A	N/A
EAST ASIA AND THE PACIFIC	PREVENTION	$289,620	CHECK/WIRE TRANSFER	$0	N/A	N/A
EUROPE (INCLUDING ICELAND AND GREENLAND)	PREVENTION	$900,000	CHECK/WIRE TRANSFER	$0	N/A	N/A
EUROPE (INCLUDING ICELAND AND GREENLAND)	BETA CELL REPLACEMENT	$60,038	CHECK/WIRE TRANSFER	$0	N/A	N/A
NORTH AMERICA	ARTIFICIAL PANCREAS	$423,091	CHECK/WIRE TRANSFER	$0	N/A	N/A
EUROPE (INCLUDING ICELAND AND GREENLAND)	BETA CELL REGENERATION	$63,131	CHECK/WIRE TRANSFER	$0	N/A	N/A
EUROPE (INCLUDING ICELAND AND GREENLAND)	PREVENTION	$399,851	CHECK/WIRE TRANSFER	$0	N/A	N/A
EAST ASIA AND THE PACIFIC	PREVENTION	$296,077	CHECK/WIRE TRANSFER	$0	N/A	N/A
EUROPE (INCLUDING ICELAND AND GREENLAND)	ARTIFICIAL PANCREAS	$50,000	CHECK/WIRE TRANSFER	$0	N/A	N/A
EAST ASIA AND THE PACIFIC	METABOLIC CONTROL	$742,308	CHECK/WIRE TRANSFER	$0	N/A	N/A

Field	Value	IRS element (for citing)
Total501c3 Org	0	Total501c3OrgCnt
Total Other Org	61	TotalOtherOrgCnt
Transfer To Foreign Corp	Yes (1)	TransferToForeignCorpInd
Interest In Foreign Trust	0	InterestInForeignTrustInd
Foreign Corp Ownership	Yes (1)	ForeignCorpOwnershipInd
Passive Foreign Investmest Co	Yes (1)	PassiveForeignInvestmestCoInd
Foreign Partnership	0	ForeignPartnershipInd
Boycott Countries	Yes (1)	BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
PART I, LINE 2:	GRANT MONITORING PROCEDURES RESEARCH GRANTS ARE AWARDED BY JDRF INTERNATIONAL ("JDRFI") WITH THE SUPPORT OF JDRFI'S RESEARCH COMMITTEE COMPRISED OF "JDRFI BOARD MEMBERS AND OTHER VOLUNTEERS" FOLLOWING THE RECOMMENDATIONS OF AN IN-HOUSE TEAM OF PROFESSIONAL SCIENTIFIC STAFF AND WITH INPUT FROM EXTERNAL SCIENTIFIC REVIEWERS. THE REVIEW PROCESS INCLUDES THE FOLLOWING CRITERIA: (1) THE SCIENTIFIC MERIT OF THE PROPOSED RESEARCH OUTLINED IN A GRANT APPLICATION AND (2) THE RELATIONSHIP OF THE PROPOSED RESEARCH TO JDRF'S GOAL TO IMPROVE LIVES TODAY AND TOMORROW BY ACCELERATING LIFE-CHANGING BREAKTHROUGHS TO CURE, PREVENT AND TREAT T1D AND ITS COMPLICATIONS. THE SCIENTIFIC RESEARCH TEAM AND GRANT ADMINISTRATION STAFF MAINTAIN CLOSE CONTACT WITH GRANTEES, PROVIDING ADVICE AND EVALUATION, REVIEWING PROGRESS REPORTS, REVIEWING RESEARCH EXPENDITURES VERSUS AGREED BUDGETS, AND HELPING DISSEMINATE RESEARCH RESULTS.
PART III ACCOUNTING METHOD:
PART II, LINES 2 AND 3:	WHILE MANY FOREIGN GRANTEES MAY BE RECOGNIZED AS CHARITIES IN THEIR RESPECTIVE COUNTRY OR AS 501(C)(3) ORGANIZATIONS BY THE IRS, JDRF DOES NOT HAVE A FEASIBLE WAY TO VALIDATE FOREIGN TAX EXEMPTION AND CONSERVATIVELY CLASSIFIES ALL FOREIGN GRANTS AS OTHER.

Schedule G IRS990ScheduleG

Field	Value	IRS element (for citing)
Mail Solicitations	Yes (X)	MailSolicitationsInd
Email Solicitations	Yes (X)	EmailSolicitationsInd
In Person Solicitations	Yes (X)	InPersonSolicitationsInd
Solicitation Of Non Govt Grants	Yes (X)	SolicitationOfNonGovtGrantsInd
Special Fundraising Events	Yes (X)	SpecialFundraisingEventsInd
Agrmt Prof Fundraising Acty	Yes (1)	AgrmtProfFundraisingActyInd

Fundraiser Activity Info FundraiserActivityInfoGrp (4 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	ActivityActivityTxt	Fundraiser Control Of FundsFundraiserControlOfFundsInd	Gross ReceiptsGrossReceiptsAmt	Retained By ContractorRetainedByContractorAmt	Net To OrganizationNetToOrganizationAmt
BLUE STATE DIGITAL
41 FLATBUSH AVENUE 8TH FL	BROOKLYN	NY	11217	DIRECT APPEAL FUNDRAISING SERVICES	0	$4,397,672	$747,732	$3,649,940
THE PURSUANT GROUP
15660 NORTH DALLAS PARKWAY SUITE 1	DALLAS	TX	75248	DIRECT APPEAL FUNDRAISING SERVICES	0	$2,651,598	$495,200	$2,156,398
CARS (CHARITABLE ADULT RIDES AND SERVICES)
4669 MURPHY CANYON RD 200	SAN DIEGO	CA	92123	CAR DONATION	Yes (1)	$186,460	$33,140	$153,320
CASWELL ZACHRY GRIZZARD
6301 GASTON AVENUE SUITE 715	DALLAS	TX	75214	PLANNED GIVING MARKETING	0	$10,000	$111,991	-$101,991

Field	Value	IRS element (for citing)
Total Gross Receipts	$7,245,730	TotalGrossReceiptsAmt
Total Retained By Contractors	$1,388,063	TotalRetainedByContractorsAmt
Total Net To Organization	$5,857,667	TotalNetToOrganizationAmt
Licensed States	AL	LicensedStatesCd
Licensed States	AK	LicensedStatesCd
Licensed States	AZ	LicensedStatesCd
Licensed States	AR	LicensedStatesCd
Licensed States	CA	LicensedStatesCd
Licensed States	CO	LicensedStatesCd
Licensed States	CT	LicensedStatesCd
Licensed States	DC	LicensedStatesCd
Licensed States	FL	LicensedStatesCd
Licensed States	GA	LicensedStatesCd
Licensed States	HI	LicensedStatesCd
Licensed States	IL	LicensedStatesCd
Licensed States	KS	LicensedStatesCd
Licensed States	KY	LicensedStatesCd
Licensed States	LA	LicensedStatesCd
Licensed States	ME	LicensedStatesCd
Licensed States	MD	LicensedStatesCd
Licensed States	MA	LicensedStatesCd
Licensed States	MI	LicensedStatesCd
Licensed States	MN	LicensedStatesCd
Licensed States	MS	LicensedStatesCd
Licensed States	MO	LicensedStatesCd
Licensed States	NV	LicensedStatesCd
Licensed States	NH	LicensedStatesCd
Licensed States	NJ	LicensedStatesCd
Licensed States	NM	LicensedStatesCd
Licensed States	NY	LicensedStatesCd
Licensed States	NC	LicensedStatesCd
Licensed States	ND	LicensedStatesCd
Licensed States	OH	LicensedStatesCd
Licensed States	OK	LicensedStatesCd
Licensed States	OR	LicensedStatesCd
Licensed States	PA	LicensedStatesCd
Licensed States	RI	LicensedStatesCd
Licensed States	SC	LicensedStatesCd
Licensed States	TN	LicensedStatesCd
Licensed States	UT	LicensedStatesCd
Licensed States	VA	LicensedStatesCd
Licensed States	WA	LicensedStatesCd
Licensed States	WV	LicensedStatesCd
Licensed States	WI	LicensedStatesCd

Fundraising Event Information FundraisingEventInformationGrp

Field	Value	IRS element (for citing)
Event1	ILLINOIS GALA	Event1Nm
Gross Receipts Event1	$15,021,026	GrossReceiptsEvent1Amt
Charitable Contri Event1	$14,079,351	CharitableContriEvent1Amt
Gross Revenue Event1	$941,675	GrossRevenueEvent1Amt
Non Cash Prizes Event1	$0	NonCashPrizesEvent1Amt
Rent Facility Costs Event1	$137,885	RentFacilityCostsEvent1Amt
Food And Beverage Event1	$298,546	FoodAndBeverageEvent1Amt
Entertainment Event1	$372,611	EntertainmentEvent1Amt
Other Direct Expenses Event1	$132,633	OtherDirectExpensesEvent1Amt
Event2	S. TEXAS BALL	Event2Nm
Gross Receipts Event2	$2,872,927	GrossReceiptsEvent2Amt
Charitable Contri Event2	$2,294,620	CharitableContriEvent2Amt
Gross Revenue Event2	$578,307	GrossRevenueEvent2Amt
Non Cash Prizes Event2	$0	NonCashPrizesEvent2Amt
Rent Facility Costs Event2	$4,383	RentFacilityCostsEvent2Amt
Food And Beverage Event2	$239,681	FoodAndBeverageEvent2Amt
Entertainment Event2	$231,208	EntertainmentEvent2Amt
Other Direct Expenses Event2	$103,035	OtherDirectExpensesEvent2Amt
Other Events Total	290	OtherEventsTotalCnt
Gross Receipts Other Events	$98,665,933	GrossReceiptsOtherEventsAmt
Charitable Contri Other Events	$83,443,042	CharitableContriOtherEventsAmt
Gross Revenue Other Events	$15,222,891	GrossRevenueOtherEventsAmt
Non Cash Prizes Other Events	$0	NonCashPrizesOtherEventsAmt
Rent Fclty Costs Other Events	$2,549,670	RentFcltyCostsOtherEventsAmt
Food And Beverage Other Events	$2,740,998	FoodAndBeverageOtherEventsAmt
Entertainment Other Events	$3,774,565	EntertainmentOtherEventsAmt
Oth Direct Expnss Other Events	$6,157,658	OthDirectExpnssOtherEventsAmt
Gross Receipts Total	$116,559,886	GrossReceiptsTotalAmt
Charitable Contributions Tot	$99,817,013	CharitableContributionsTotAmt
Gross Revenue Total Events	$16,742,873	GrossRevenueTotalEventsAmt
Rent Fclty Costs Total Events	$2,691,938	RentFcltyCostsTotalEventsAmt
Food And Beverage Total Events	$3,279,225	FoodAndBeverageTotalEventsAmt
Entertainment Total Events	$4,378,384	EntertainmentTotalEventsAmt
Oth Direct Expnss Total Events	$6,393,326	OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events	$16,742,873	DirectExpenseSummaryEventsAmt
Net Income Summary	$0	NetIncomeSummaryAmt

Gaming Information GamingInformationGrp

Field	Value	IRS element (for citing)
Gross Revenue Other Gaming	$738,140	GrossRevenueOtherGamingAmt
Cash Prizes Other Gaming	$10,000	CashPrizesOtherGamingAmt
Non Cash Prizes Other Gaming	$0	NonCashPrizesOtherGamingAmt
Volunteer Labor Other Gaming	0	VolunteerLaborOtherGamingInd
Gross Revenue Total Gaming	$738,140	GrossRevenueTotalGamingAmt
Cash Prizes Total Gaming	$10,000	CashPrizesTotalGamingAmt
Direct Expense Summary Gaming	$10,000	DirectExpenseSummaryGamingAmt
Net Gaming Income Summary	$728,140	NetGamingIncomeSummaryAmt

Field	Value	IRS element (for citing)
States Where Gaming Conducted	AL	StatesWhereGamingConductedCd
States Where Gaming Conducted	AK	StatesWhereGamingConductedCd
States Where Gaming Conducted	AZ	StatesWhereGamingConductedCd
States Where Gaming Conducted	CA	StatesWhereGamingConductedCd
States Where Gaming Conducted	CO	StatesWhereGamingConductedCd
States Where Gaming Conducted	CT	StatesWhereGamingConductedCd
States Where Gaming Conducted	DC	StatesWhereGamingConductedCd
States Where Gaming Conducted	FL	StatesWhereGamingConductedCd
States Where Gaming Conducted	GA	StatesWhereGamingConductedCd
States Where Gaming Conducted	HI	StatesWhereGamingConductedCd
States Where Gaming Conducted	IL	StatesWhereGamingConductedCd
States Where Gaming Conducted	KS	StatesWhereGamingConductedCd
States Where Gaming Conducted	KY	StatesWhereGamingConductedCd
States Where Gaming Conducted	LA	StatesWhereGamingConductedCd
States Where Gaming Conducted	ME	StatesWhereGamingConductedCd
States Where Gaming Conducted	MD	StatesWhereGamingConductedCd
States Where Gaming Conducted	MA	StatesWhereGamingConductedCd
States Where Gaming Conducted	MI	StatesWhereGamingConductedCd
States Where Gaming Conducted	MN	StatesWhereGamingConductedCd
States Where Gaming Conducted	MS	StatesWhereGamingConductedCd
States Where Gaming Conducted	MO	StatesWhereGamingConductedCd
States Where Gaming Conducted	NV	StatesWhereGamingConductedCd
States Where Gaming Conducted	NH	StatesWhereGamingConductedCd
States Where Gaming Conducted	NJ	StatesWhereGamingConductedCd
States Where Gaming Conducted	NM	StatesWhereGamingConductedCd
States Where Gaming Conducted	NY	StatesWhereGamingConductedCd
States Where Gaming Conducted	NC	StatesWhereGamingConductedCd
States Where Gaming Conducted	ND	StatesWhereGamingConductedCd
States Where Gaming Conducted	OH	StatesWhereGamingConductedCd
States Where Gaming Conducted	OK	StatesWhereGamingConductedCd
States Where Gaming Conducted	OR	StatesWhereGamingConductedCd
States Where Gaming Conducted	PA	StatesWhereGamingConductedCd
States Where Gaming Conducted	RI	StatesWhereGamingConductedCd
States Where Gaming Conducted	SC	StatesWhereGamingConductedCd
States Where Gaming Conducted	TN	StatesWhereGamingConductedCd
States Where Gaming Conducted	UT	StatesWhereGamingConductedCd
States Where Gaming Conducted	VA	StatesWhereGamingConductedCd
States Where Gaming Conducted	WA	StatesWhereGamingConductedCd
States Where Gaming Conducted	WV	StatesWhereGamingConductedCd
States Where Gaming Conducted	WI	StatesWhereGamingConductedCd
Licensed	Yes (1)	LicensedInd
License Suspended Etc	0	LicenseSuspendedEtcInd
Gaming With Nonmembers	0	GamingWithNonmembersInd
Member Of Other Entity	0	MemberOfOtherEntityInd
Gaming Other Facility	1.00000	GamingOtherFacilityPct

Persons With Books Name PersonsWithBooksName

Field	Value	IRS element (for citing)
Business Name Line1	KIMBERLY ZINGALE MANAGER FINANCIAL REPORTING AND COMPLIANCE - JDRF	BusinessNameLine1Txt

Persons With Books US Address PersonsWithBooksUSAddress

Field	Value	IRS element (for citing)
Address Line1	200 VESEY STREET 28TH FLOOR	AddressLine1Txt
City	NEW YORK	CityNm
State Abbreviation	NY	StateAbbreviationCd
ZIP	10281	ZIPCd

Field	Value	IRS element (for citing)
Cntrct With3rd Prty For Game Rev	0	CntrctWith3rdPrtyForGameRevInd

Gaming Manager Business Name GamingManagerBusinessName

Field	Value	IRS element (for citing)
Business Name Line1	ROBERT KING CFO - JDRF	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Gaming Manager Services Prov	FILING GAMING APPLICATIONS AND REPORTS	GamingManagerServicesProvTxt
Gaming Manager Is Director Ofcr	Yes (X)	GamingManagerIsDirectorOfcrInd
Charitable Distribution Rqr	0	CharitableDistributionRqrInd

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	PART I, LINE 2:	FormAndLineReferenceDesc
Explanation	CHARITABLE ADULT RIDES AND SERVICES (CARS) IS A THIRD-PARTY CAR DONATION COMPANY THAT HANDLES ALL ASPECTS OF CARS DONATED TO JDRF. DONORS CALL A TOLL-FREE NUMBER AND ARE PUT IN CONTACT WITH A TOWING SERVICE IN THEIR AREA. AFTER THE CAR IS DONATED, CARS HANDLES ALL IRS 1098-C REPORTING. CARS WITHHELD $20,763 FROM THE GROSS SALES FOR VARIOUS SELLING EXPENSES. JDRF PAID FUNDRAISING EXPENSES OF $383,046 FOR POSTAGE AND $866,254 FOR PRINTING TO THE PURSUANT GROUP. THE INVOICES PROVIDE AN ITEMIZED LIST OF SERVICES AND EXPENSES. JDRF PAID FUNDRAISING EXPENSES OF $28,946 FOR POSTAGE TO CASWELL. THE INVOICES PROVIDE AN ITEMIZED LIST OF SERVICES AND EXPENSES.	ExplanationTxt

Schedule I IRS990ScheduleI

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (1)	GrantRecordsMaintainedInd

Recipient Table RecipientTable (129 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	Recipient EINRecipientEIN	IRC SectionIRCSectionDesc	Cash GrantCashGrantAmt	Non Cash AssistanceNonCashAssistanceAmt	Valuation Method UsedValuationMethodUsedDesc	Non Cash AssistanceNonCashAssistanceDesc	Purpose Of GrantPurposeOfGrantTxt	Address Line2USAddress/AddressLine2Txt
ALBERT EINSTEIN COLLEGE OF MEDICINE
1300 MORRIS PARK AVENUE	BRONX	NY	10461	830621846	501(C)(3)	$980,547	$0	N/A	N/A	PSYCHOSOCIAL
AVERA MCKENNAN
1325 S CLIFF AVENUE	SIOUX FALLS	SD	57108	301043916	501(C)(3)	$2,480,110	$0	N/A	N/A	PSYCHOSOCIAL
BAYLOR COLLEGE OF MEDICINE
PO BOX 301207	DALLAS	TX	753031207	741613878	501(C)(3)	$64,999	$0	N/A	N/A	PSYCHOSOCIAL
BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE
1500 E DUARTE RD	DUARTE	CA	91010	953432210	501(C)(3)	$395,153	$0	N/A	N/A	BETA CELL REGENERATION
BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE
1500 E DUARTE RD	DUARTE	CA	91010	953432210	501(C)(3)	$300,000	$0	N/A	N/A	BETA CELL REPLACEMENT
BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE
1500 E DUARTE RD	DUARTE	CA	91010	953432210	501(C)(3)	$300,000	$0	N/A	N/A	IMMUNOTHERAPIES
BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE
1500 E DUARTE RD	DUARTE	CA	91010	953432210	501(C)(3)	$66,000	$0	N/A	N/A	TRANSPORTFOLIO
BETH ISRAEL DEACONESS MEDICAL CENTER INC
330 BROOKLINE AVE	BOSTON	MA	02215	042103881	501(C)(3)	$110,000	$0	N/A	N/A	IMMUNOTHERAPIES
BOSTON CHILDREN'S HOSPITAL
300 LONGWOOD AVENUE	BOSTON	MA	02115	042774441	501(C)(3)	$595,000	$0	N/A	N/A	BETA CELL REPLACEMENT
BOSTON COLLEGE
140 COMMONWEALTH AVENUE	CHESTNUT HILL	MA	02467	042103545	501(C)(3)	$110,000	$0	N/A	N/A	IMMUNOTHERAPIES
BROWN UNIVERSITY
164 ANGELL STREET-BOX 1929	PROVIDENCE	RI	02912	050258809	501(C)(3)	$515,513	$0	N/A	N/A	BETA CELL REPLACEMENT
CARNEGIE MELLON UNIVERSITY
PO BOX 371032	PITTSBURGH	PA	15213	250969449	501(C)(3)	$249,996	$0	N/A	N/A	BETA CELL REPLACEMENT
CASE WESTERN RESERVE UNIVERSITY
10900 EUCLID AVE STE 357	CLEVELAND	OH	44106	341018992	501(C)(3)	$200,000	$0	N/A	N/A	IMMUNOTHERAPIES
CHILDREN'S HOSPITAL OF PHILADELPHIA
3401 CIVIC CENTER BLVD ABRAMSON	PHILADELPHIA	PA	19104	231352166	501(C)(3)	$150,000	$0	N/A	N/A	PREVENTION	RESEARCH CENTER
CIVICA RX
2912 W EXECUTIVE PKWY STE 325	LEHI	UT	840434622	844514428	501(C)(3)	$3,000,000	$0	N/A	N/A	MISSION
COLORADO SCHOOL OF MINES
1500 ILLINOIS ST	GOLDEN	CO	80401	846000551	501(C)(3)	$110,000	$0	N/A	N/A	BETA CELL REGENERATION
CORNELL UNIVERSITY
373 PINE TREE RD CORNELL UNIVERSITY	ITHACA	NY	14850	150532082	501(C)(3)	$110,000	$0	N/A	N/A	BETA CELL REPLACEMENT
CRITICAL PATH INSTITUTE (C-PATH)
1730 EAST RIVER ROAD 200	TUCSON	AZ	85718	201991334	501(C)(3)	$266,757	$0	N/A	N/A	IMMUNOTHERAPIES
DUKE UNIVERSITY
PO BOX 602651	CHARLOTTE	NC	282602651	560532129	501(C)(3)	$65,683	$0	N/A	N/A	METABOLIC CONTROL
DUKE UNIVERSITY
PO BOX 602651	CHARLOTTE	NC	282602651	560532129	501(C)(3)	$519,452	$0	N/A	N/A	PSYCHOSOCIAL
ENABLE BIOSCIENCES INC
953 INDIANA ST	SAN FRANCISCO	CA	94107	474916653	N/A	$114,000	$0	N/A	N/A	PREVENTION
GEISINGER CLINIC
100 N ACADEMY AVE	DANVILLE	PA	17822	236291113	501(C)(3)	$495,711	$0	N/A	N/A	PREVENTION
GEORGIA TECH RESEARCH CORPORATION
PO BOX 100117	ATLANTA	GA	30384	580603146	501(C)(3)	$136,904	$0	N/A	N/A	BETA CELL REPLACEMENT
GINER INC
89 RUMFORD AVE	NEWTON	MA	02466	042529800	N/A	$19,984	$0	N/A	N/A	BETA CELL REPLACEMENT
ILLINOIS INSTITUTE OF TECHNOLOGY
IIT GRANTS LOCKBOX 777562 7562	CHICAGO	IL	606777005	362170136	501(C)(3)	$94,500	$0	N/A	N/A	ARTIFICIAL PANCREAS	SOLUTION CENTER
INDIANA BIOSCIENCES RESEARCH INSTITUTE
1210 WATERWAY BLVD STE 2000	INDIANAPOLIS	IN	46202	462882271	501(C)(3)	$109,997	$0	N/A	N/A	BETA CELL REGENERATION
INDIANA UNIVERSITY
PO BOX 66057	DETROIT	MI	482780867	356001673	501(C)(3)	$150,000	$0	N/A	N/A	PREVENTION
INDIANA UNIVERSITY
PO BOX 66057	INDIANAPOLIS	IN	462666057	356001673	501(C)(3)	$777,404	$0	N/A	N/A	BETA CELL REGENERATION
INTEGRATED MEDICAL SENSORS INC
73 OVERBROOK	IRVINE	CA	92620	474751319	N/A	$80,000	$0	N/A	N/A	ARTIFICIAL PANCREAS
ITOLERANCE INC
1221 SHAFTER STREET	SAN MATEO	CA	94402	853086959	N/A	$170,000	$0	N/A	N/A	BETA CELL REPLACEMENT
JAEB CENTER FOR HEALTH RESEARCH
15310 AMBERLY DR STE 350	TAMPA	FL	33647	593187624	501(C)(3)	$332,283	$0	N/A	N/A	COMPLICATIONS
JAEB CENTER FOR HEALTH RESEARCH
15310 AMBERLY DR STE 350	TAMPA	FL	33647	593187624	501(C)(3)	$204,389	$0	N/A	N/A	PREVENTION
JOHNS HOPKINS UNIVERSITY
3400 N CHARLES STREET	BALTIMORE	MD	21218	520595110	501(C)(3)	$350,000	$0	N/A	N/A	BETA CELL REPLACEMENT
JOHNS HOPKINS UNIVERSITY
3400 N CHARLES STREET	BALTIMORE	MD	21218	520595110	501(C)(3)	$198,000	$0	N/A	N/A	IMMUNOTHERAPIES
JOSLIN DIABETES CENTER INC
ONE JOSLIN PLACE	BOSTON	MA	02215	042203836	501(C)(3)	$311,228	$0	N/A	N/A	BETA CELL REGENERATION
JOSLIN DIABETES CENTER INC
ONE JOSLIN PLACE	BOSTON	MA	02215	042203836	501(C)(3)	$200,000	$0	N/A	N/A	BETA CELL REPLACEMENT
MASSACHUSETTS GENERAL HOSPITAL
101 HUNTINGTON AVE 3RD FLOOR	BOSTON	MA	02199	042697983	501(C)(3)	$196,140	$0	N/A	N/A	BETA CELL REGENERATION
MASSACHUSETTS GENERAL HOSPITAL
101 HUNTINGTON AVE 3RD FLOOR	BOSTON	MA	02199	042697983	501(C)(3)	$274,164	$0	N/A	N/A	BETA CELL REPLACEMENT
MASSACHUSETTS GENERAL HOSPITAL
101 HUNTINGTON AVE 3RD FLOOR	BOSTON	MA	02199	042697983	501(C)(3)	$100,000	$0	N/A	N/A	IMMUNOTHERAPIES
MASSACHUSETTS GENERAL HOSPITAL
101 HUNTINGTON AVE 3RD FLOOR	BOSTON	MA	02199	042697983	501(C)(3)	$65,000	$0	N/A	N/A	PSYCHOSOCIAL
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
77 MASSACHUSETTS AVENUE	CAMBRIDGE	MA	02139	042103594	501(C)(3)	$65,683	$0	N/A	N/A	BETA CELL REPLACEMENT
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
77 MASSACHUSETTS AVENUE	CAMBRIDGE	MA	02139	042103594	501(C)(3)	$95,000	$0	N/A	N/A	METABOLIC CONTROL
MAYO CLINIC
200 FIRST STREET SW	ROCHESTER	MN	559050001	416011702	501(C)(3)	$200,000	$0	N/A	N/A	BETA CELL REGENERATION
MILLIMAN
1301 5TH AVE STE 3800	SEATTLE	WA	981012635	910675641	N/A	$430,000	$0	N/A	N/A	TRANSPORTFOLIO
NEURODON LLC
9800 CONNECTICUT DRIVE	CROWN POINT	IN	46307	465375254	N/A	$184,000	$0	N/A	N/A	BETA CELL REGENERATION
NEW YORK MEDICAL COLLEGE
40 SUNSHINE COTTAGE RD	VALHALLA	NY	10595	131099420	501(C)(3)	$250,000	$0	N/A	N/A	BETA CELL REGENERATION	ADMINISTRATION BUILDING
NEW YORK STEM CELL FOUNDATION INC
619 WEST 54TH STREET 3RD FLOOR	NEW YORK	NY	10019	202905531	501(C)(3)	$450,000	$0	N/A	N/A	BETA CELL REPLACEMENT
NORTHWESTERN UNIVERSITY
633 CLARK ST - ROOM G-547	EVANSTON	IL	60208	362167817	501(C)(3)	$99,978	$0	N/A	N/A	COMPLICATIONS
NORTHWESTERN UNIVERSITY
633 CLARK ST - ROOM G-547	EVANSTON	IL	60208	362167817	501(C)(3)	$220,000	$0	N/A	N/A	IMMUNOTHERAPIES
OHIO UNIVERSITY
1 OHIO UNIVERSITY DRIVE	ATHENS	OH	45701	316402113	501(C)(3)	$110,000	$0	N/A	N/A	BETA CELL REGENERATION
OREGON HEALTH & SCIENCE UNIVERSITY
3181 SW SAM JACKSON PARK RD	PORTLAND	OR	97239	931176109	501(C)(3)	$199,598	$0	N/A	N/A	ARTIFICIAL PANCREAS
OREGON HEALTH & SCIENCE UNIVERSITY
3181 SW SAM JACKSON PARK RD	PORTLAND	OR	97239	931176109	501(C)(3)	$25,000	$0	N/A	N/A	PSYCHOSOCIAL
PHYSIOLOGIC DEVICES INC
2232 OLD STAGECOACH TRAIL	ALPINE	CA	91901	800917839	N/A	$130,000	$0	N/A	N/A	ARTIFICIAL PANCREAS
PRESIDENT AND FELLOWS OF HARVARD COLLEGE
PO BOX 415649	BOSTON	MA	022415649	042103580	501(C)(3)	$6,499,999	$0	N/A	N/A	BETA CELL REPLACEMENT
QUAESTIO GLOBAL PARTNERS LLC
ONE KNOLLWOOD TERRACE	CHESTER	NJ	07930	208396264	N/A	$45,000	$0	N/A	N/A	IMMUNOTHERAPIES
RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA
PO BOX 400195	CHARLOTTESVILLE	VA	229044195	546001796	501(C)(3)	$212,906	$0	N/A	N/A	ARTIFICIAL PANCREAS
RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA
PO BOX 400195	CHARLOTTESVILLE	VA	229044195	546001796	501(C)(3)	$110,000	$0	N/A	N/A	BETA CELL REPLACEMENT
RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA
PO BOX 400195	CHARLOTTESVILLE	VA	229044195	546001796	501(C)(3)	$150,000	$0	N/A	N/A	IMMUNOTHERAPIES
RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA
PO BOX 400195	CHARLOTTESVILLE	VA	229044195	546001796	501(C)(3)	$300,000	$0	N/A	N/A	PREVENTION
REGENTS OF THE UNIVERSITY OF COLORADO
1800 GRANT STREET 8TH FLOOR	DENVER	CO	80203	846000555	501(C)(3)	$150,000	$0	N/A	N/A	ARTIFICIAL PANCREAS
REGENTS OF THE UNIVERSITY OF COLORADO
1800 GRANT STREET 8TH FLOOR	DENVER	CO	80203	846000555	501(C)(3)	$578,994	$0	N/A	N/A	COMPLICATIONS
REGENTS OF THE UNIVERSITY OF COLORADO
1800 GRANT STREET 8TH FLOOR	DENVER	CO	80203	846000555	501(C)(3)	$562,623	$0	N/A	N/A	IMMUNOTHERAPIES
REGENTS OF THE UNIVERSITY OF COLORADO
1800 GRANT STREET 8TH FLOOR	DENVER	CO	80203	846000555	501(C)(3)	$1,204,249	$0	N/A	N/A	METABOLIC CONTROL
REGENTS OF THE UNIVERSITY OF COLORADO
1800 GRANT STREET 8TH FLOOR	DENVER	CO	80203	846000555	501(C)(3)	$1,468,624	$0	N/A	N/A	PREVENTION
REGENTS OF THE UNIVERSITY OF COLORADO
1800 GRANT STREET 8TH FLOOR	DENVER	CO	80203	846000555	501(C)(3)	$150,000	$0	N/A	N/A	PSYCHOSOCIAL
REGENTS OF THE UNIVERSITY OF MICHIGAN
3003 S STATE STREET 5TH FLOOR	ANN ARBOR	MI	48109	386006309	501(C)(3)	$1,578,838	$0	N/A	N/A	BETA CELL REPLACEMENT	WOLVERINE TOWER
REGENTS OF THE UNIVERSITY OF MICHIGAN
3003 S STATE STREET 5TH FLOOR	ANN ARBOR	MI	48109	386006309	501(C)(3)	$500,000	$0	N/A	N/A	COMPLICATIONS	WOLVERINE TOWER
REGENTS OF THE UNIVERSITY OF MINNESOTA
200 OAK ST SE	MINNEAPOLIS	MN	55455	416007513	501(C)(3)	$348,768	$0	N/A	N/A	ARTIFICIAL PANCREAS
REGENTS OF THE UNIVERSITY OF MINNESOTA
200 OAK ST SE	MINNEAPOLIS	MN	55455	416007513	501(C)(3)	$300,000	$0	N/A	N/A	BETA CELL REGENERATION
RUTGERS THE STATE UNIVERSITY OF NEW JERSEY
33 KNIGHTSBRIDGE ROAD 2ND FLOOR	PISCATAWAY	NJ	088543925	450583085	501(C)(3)	$291,509	$0	N/A	N/A	PREVENTION	EAST WING
SALK INSTITUTE FOR BIOLOGICAL STUDIES
10010 N TORREY PINES ROAD	LA JOLLA	CA	92037	952160097	501(C)(3)	$110,000	$0	N/A	N/A	BETA CELL REGENERATION
SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE
10901 NORTH TORREY PINES ROAD	LA JOLLA	CA	92037	510197108	501(C)(3)	$330,000	$0	N/A	N/A	BETA CELL REGENERATION
STANFORD UNIVERSITY
PO BOX 44253	SAN FRANCISCO	CA	941444253	941156365	501(C)(3)	$200,000	$0	N/A	N/A	ARTIFICIAL PANCREAS
STANFORD UNIVERSITY
PO BOX 44253	SAN FRANCISCO	CA	941444253	941156365	501(C)(3)	$64,728	$0	N/A	N/A	BETA CELL REGENERATION
STANFORD UNIVERSITY
PO BOX 44253	SAN FRANCISCO	CA	941444253	941156365	501(C)(3)	$66,900	$0	N/A	N/A	BETA CELL REPLACEMENT
STANFORD UNIVERSITY
PO BOX 44253	SAN FRANCISCO	CA	941444253	941156365	501(C)(3)	$399,999	$0	N/A	N/A	IMMUNOTHERAPIES
STANFORD UNIVERSITY
PO BOX 44253	SAN FRANCISCO	CA	941444253	941156365	501(C)(3)	$964,998	$0	N/A	N/A	METABOLIC CONTROL
STANFORD UNIVERSITY
PO BOX 44253	SAN FRANCISCO	CA	941444253	941156365	501(C)(3)	$150,000	$0	N/A	N/A	PSYCHOSOCIAL
THE FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION INC
2000 LEVY AVENUE BUILDING A SUITE	TALLAHASSEE	FL	32310	593211153	501(C)(3)	$300,000	$0	N/A	N/A	PREVENTION	351
THE LUNDQUIST INSTITUTE
1124 WEST CARSON ST	TORRANCE	CA	90502	952138184	501(C)(3)	$1,358,963	$0	N/A	N/A	MISSION
THE METHODIST HOSPITAL RESEARCH INSTITUTE
6670 BERTNER AVE	HOUSTON	TX	77030	870721923	501(C)(3)	$259,699	$0	N/A	N/A	BETA CELL REGENERATION
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA LOS ANGELES
PAYMENT SOLUTIONS AND COMPLIANCE	LOS ANGELES	CA	900957089	956006143	501(C)(3)	$330,000	$0	N/A	N/A	BETA CELL REPLACEMENT	BOX 957089 1125 MURPHY HALL 405 HIL
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO
490 ILLINOIS STREET 4TH FLOOR	SAN FRANCISCO	CA	941430692	946036493	501(C)(3)	$500,000	$0	N/A	N/A	BETA CELL REGENERATION
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO
490 ILLINOIS STREET 4TH FLOOR	SAN FRANCISCO	CA	941430692	946036493	501(C)(3)	$600,000	$0	N/A	N/A	BETA CELL REPLACEMENT
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO
490 ILLINOIS STREET 4TH FLOOR	SAN FRANCISCO	CA	941430692	946036493	501(C)(3)	$1,829,999	$0	N/A	N/A	IMMUNOTHERAPIES
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO
490 ILLINOIS STREET 4TH FLOOR	SAN FRANCISCO	CA	941430692	946036493	501(C)(3)	$199,999	$0	N/A	N/A	METABOLIC CONTROL
THE SCRIPPS RESEARCH INSTITUTE
10550 NORTH TORREY PINES ROAD	LA JOLLA	CA	92037	330435954	501(C)(3)	$93,524	$0	N/A	N/A	IMMUNOTHERAPIES
THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
104 AIRPORT DRIVE-SUITE 2200	CHAPEL HILL	NC	275991350	566001393	501(C)(3)	$95,000	$0	N/A	N/A	IMMUNOTHERAPIES
TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
PO BOX 29789-GENERAL POST OFFICE	NEW YORK	NY	100879789	135598093	501(C)(3)	$400,000	$0	N/A	N/A	ARTIFICIAL PANCREAS
TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
PO BOX 29789-GENERAL POST OFFICE	NEW YORK	NY	100879789	135598093	501(C)(3)	$110,000	$0	N/A	N/A	BETA CELL REGENERATION
TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
3451 WALNUT STREET FRANKLIN	PHILADEPHIA	PA	191046205	231352685	501(C)(3)	$349,999	$0	N/A	N/A	BETA CELL REPLACEMENT	BUILDING 5TH FLOOR
TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
3451 WALNUT STREET FRANKLIN	PHILADELPHIA	PA	191046205	231352685	501(C)(3)	$66,900	$0	N/A	N/A	IMMUNOTHERAPIES	BUILDING 5TH FLOOR
TUFTS UNIVERSITY
419 BOSTON AVE	MEDFORD	MA	02155	042103634	501(C)(3)	$100,000	$0	N/A	N/A	IMMUNOTHERAPIES
UNITIO INC
11 AVENUE DE LAFAYETTE 5TH FLOOR	BOSTON	MA	02111	451623549	501(C)(3)	$275,000	$0	N/A	N/A	IMMUNOTHERAPIES
UNIVERSITY OF ALABAMA AT BIRMINGHAM
1720 2ND AVE S AB 990	BIRMINGHAM	AL	352940109	636005396	501(C)(3)	$150,000	$0	N/A	N/A	BETA CELL REPLACEMENT
UNIVERSITY OF CALIFORNIA DAVIS
PO BOX 989062	WEST SACRAMENTO	CA	957989062	946036494	501(C)(3)	$150,000	$0	N/A	N/A	BETA CELL REGENERATION
UNIVERSITY OF CALIFORNIA SAN DIEGO
9500 GILMAN DRIVE DEPT 0009	LA JOLLA	CA	92093	956006144	501(C)(3)	$266,666	$0	N/A	N/A	ARTIFICIAL PANCREAS
UNIVERSITY OF CALIFORNIA SAN DIEGO
9500 GILMAN DRIVE DEPT 0009	LA JOLLA	CA	92093	956006144	501(C)(3)	$343,640	$0	N/A	N/A	BETA CELL REGENERATION
UNIVERSITY OF CALIFORNIA SAN DIEGO
9500 GILMAN DRIVE DEPT 0009	LA JOLLA	CA	92093	956006144	501(C)(3)	$307,496	$0	N/A	N/A	COMPLICATIONS
UNIVERSITY OF CALIFORNIA SAN DIEGO
9500 GILMAN DRIVE DEPT 0009	LA JOLLA	CA	92093	956006144	501(C)(3)	$504,224	$0	N/A	N/A	METABOLIC CONTROL
UNIVERSITY OF FLORIDA
207 GRINTER HALL PO BOX 115500	GAINESVILLE	FL	326115500	596002052	501(C)(3)	$250,000	$0	N/A	N/A	BETA CELL REPLACEMENT
UNIVERSITY OF FLORIDA
207 GRINTER HALL PO BOX 115500	GAINESVILLE	FL	326115500	596002052	501(C)(3)	$62,958	$0	N/A	N/A	IMMUNOTHERAPIES
UNIVERSITY OF FLORIDA
207 GRINTER HALL PO BOX 115500	GAINESVILLE	FL	326115500	596002052	501(C)(3)	$250,000	$0	N/A	N/A	PREVENTION
UNIVERSITY OF KANSAS MEDICAL CENTER RESEARCH INSTITUTE INC
3901 RAINBOW BLVD	KANSAS CITY	KS	661032937	481108830	501(C)(3)	$110,000	$0	N/A	N/A	IMMUNOTHERAPIES
UNIVERSITY OF MIAMI
1320 S DIXIE HWY STE 760 212	CORAL GABLES	FL	331462919	590624458	501(C)(3)	$300,000	$0	N/A	N/A	BETA CELL REGENERATION	PEARSON HALL
UNIVERSITY OF MIAMI
1320 S DIXIE HWY STE 760 212	CORAL GABLES	FL	331462919	590624458	501(C)(3)	$307,409	$0	N/A	N/A	BETA CELL REPLACEMENT	PEARSON HALL
UNIVERSITY OF MIAMI
1320 S DIXIE HWY STE 760 212	CORAL GABLES	FL	33146	590624458	501(C)(3)	$269,613	$0	N/A	N/A	PREVENTION	PEARSON HALL
UNIVERSITY OF NOTRE DAME
836A GRACE HALL	NOTRE DAME	IN	46556	350868188	501(C)(3)	$150,000	$0	N/A	N/A	METABOLIC CONTROL
UNIVERSITY OF PITTSBURGH
PO BOX 371220	PITTSBURGH	PA	152517220	250965591	501(C)(3)	$297,291	$0	N/A	N/A	BETA CELL REGENERATION
UNIVERSITY OF UTAH
201 S PRESIDENTS CIRCLE ROOM 406	SALT LAKE CITY	UT	84112	876000525	501(C)(3)	$173,377	$0	N/A	N/A	IMMUNOTHERAPIES
UNIVERSITY OF UTAH
201 S PRESIDENTS CIRCLE ROOM 406	SALT LAKE CITY	UT	84112	876000525	501(C)(3)	$147,269	$0	N/A	N/A	METABOLIC CONTROL
UNIVERSITY OF WASHINGTON
3917 UNIVERSITY WAY NE	SEATTLE	WA	98195	916001537	501(C)(3)	$148,232	$0	N/A	N/A	PREVENTION
UNIVERSITY OF WISCONSIN-MADISON
UW-MADISON GAR ACCOUNT RESEARCH	MILWAUKEE	WI	53278	396006492	501(C)(3)	$300,000	$0	N/A	N/A	BETA CELL REPLACEMENT	PROGRAMS-DRAWER 539
UNIVERSITY OF WISCONSIN-MADISON
UW-MADISON GAR ACCOUNT RESEARCH	MILWAUKEE	WI	53278	396006492	501(C)(3)	$402,655	$0	N/A	N/A	COMPLICATIONS	PROGRAMS-DRAWER 539
UT SOUTHWESTERN
OFFICE OF POST AWARD ADMINISTRATION	DALLAS	TX	752841765	752556007	501(C)(3)	$600,000	$0	N/A	N/A	BETA CELL REGENERATION	PO BOX 841765
VANDERBILT UNIVERSITY
PMB 407749 2301 VANDERBILT PLACE	NASHVILLE	TN	372407749	620476822	501(C)(3)	$110,000	$0	N/A	N/A	METABOLIC CONTROL
VANDERBILT UNIVERSITY MEDICAL CENTER (VUMC)
PMB 407749 2301 VANDERBILT PLACE	NASHVILLE	TN	372407749	352528741	501(C)(3)	$150,000	$0	N/A	N/A	METABOLIC CONTROL
VTV THERAPEUTICS LLC
4170 MENDENHALL OAKS PARKWAY	HIGH POINT	NC	27265	352536301	N/A	$130,000	$0	N/A	N/A	METABOLIC CONTROL
WAKE FOREST UNIVERSITY HEALTH SCIENCES
MEDICAL CENTER BLVD	WINSTONSALEM	NC	271570001	223849199	501(C)(3)	$249,999	$0	N/A	N/A	BETA CELL REPLACEMENT
WASHINGTON UNIVERSITY
CAMPUS BOX 1034 700 ROSEDALE AVENUE	ST LOUIS	MO	631121408	430653611	501(C)(3)	$214,708	$0	N/A	N/A	ARTIFICIAL PANCREAS
WASHINGTON UNIVERSITY
CAMPUS BOX 1034 700 ROSEDALE AVENUE	ST LOUIS	MO	631121408	430653611	501(C)(3)	$94,552	$0	N/A	N/A	BETA CELL REPLACEMENT
WASHINGTON UNIVERSITY
CAMPUS BOX 1034 700 ROSEDALE AVENUE	ST LOUIS	MO	631121408	430653611	501(C)(3)	$150,000	$0	N/A	N/A	PREVENTION
WAYNE STATE UNIVERSITY
42 W WARREN AVE	DETROIT	MI	482023692	386028429	501(C)(3)	$224,166	$0	N/A	N/A	METABOLIC CONTROL
WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY
1300 YORK AVE BOX 89	NEW YORK	NY	10065	131623978	501(C)(3)	$249,986	$0	N/A	N/A	BETA CELL REPLACEMENT
WILLIAM MARSH RICE UNIVERSITY
6100 MAIN STREET MS 16	HOUSTON	TX	770051892	741109620	501(C)(3)	$450,000	$0	N/A	N/A	BETA CELL REPLACEMENT
YALE UNIVERSITY
PO BOX 1873	NEW HAVEN	CT	065081873	060646973	501(C)(3)	$109,998	$0	N/A	N/A	BETA CELL REGENERATION
YALE UNIVERSITY
PO BOX 1873	NEW HAVEN	CT	065081873	060646973	501(C)(3)	$399,344	$0	N/A	N/A	IMMUNOTHERAPIES
YALE UNIVERSITY
PO BOX 1873	NEW HAVEN	CT	065081873	060646973	501(C)(3)	$110,000	$0	N/A	N/A	METABOLIC CONTROL
YALE UNIVERSITY
PO BOX 1873	NEW HAVEN	CT	065081873	060646973	501(C)(3)	$245,472	$0	N/A	N/A	PREVENTION

Field	Value	IRS element (for citing)
Total501c3 Org	120	Total501c3OrgCnt
Total Other Org	9	TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	PART I, LINE 2:	FormAndLineReferenceDesc
Explanation	RESEARCH GRANTS ARE AWARDED BY JDRF INTERNATIONAL ("JDRFI") WITH THE SUPPORT OF JDRFI'S RESEARCH COMMITTEE COMPRISED OF "JDRF INTERNATIONAL BOARD MEMBERS AND OTHER VOLUNTEERS OR THE JDRF INTERNATIONAL BOARD OF DIRECTORS FOLLOWING THE RECOMMENDATIONS OF AN IN-HOUSE TEAM OF PROFESSIONAL SCIENTIFIC STAFF AND WITH INPUT FROM EXTERNAL SCIENTIFIC REVIEWERS. THE REVIEW PROCESS INCLUDES THE FOLLOWING CRITERIA: (1) THE SCIENTIFIC MERIT OF THE PROPOSED RESEARCH OUTLINED IN A GRANT APPLICATION AND (2) THE RELATIONSHIP OF THE PROPOSED RESEARCH TO JDRF'S GOAL TO IMPROVE LIVES TODAY AND TOMORROW BY ACCELERATING LIFE-CHANGING BREAKTHROUGHS TO CURE, PREVENT AND TREAT T1D AND ITS COMPLICATIONS. THE SCIENTIFIC RESEARCH TEAM AND GRANT ADMINISTRATION STAFF MAINTAIN CLOSE CONTACT WITH GRANTEES, PROVIDING ADVICE AND EVALUATION, REVIEWING PROGRESS REPORTS, REVIEWING RESEARCH EXPENDITURES VERSUS AGREED BUDGETS, AND HELPING DISSEMINATE RESEARCH RESULTS.	ExplanationTxt

Schedule J IRS990ScheduleJ

Field	Value	IRS element (for citing)
Housing Allowance Or Residence	Yes (X)	HousingAllowanceOrResidenceInd
Written Policy Ref T And E Expnss	Yes (1)	WrittenPolicyRefTAndEExpnssInd
Substantiation Required	0	SubstantiationRequiredInd
Compensation Committee	Yes (X)	CompensationCommitteeInd
Independent Consultant	Yes (X)	IndependentConsultantInd
Form990 Of Other Organizations	Yes (X)	Form990OfOtherOrganizationsInd
Compensation Survey	Yes (X)	CompensationSurveyInd
Board Or Committee Approval	Yes (X)	BoardOrCommitteeApprovalInd
Severance Payment	Yes (1)	SeverancePaymentInd
Supplemental Nonqual Rtr Plan	0	SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm	0	EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org	0	CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs	0	CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org	0	CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs	0	CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments	Yes (1)	AnyNonFixedPaymentsInd
Initial Contract Exception	0	InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (14 entries)

TitleTitleTxt	Base Compensation Filing OrgBaseCompensationFilingOrgAmt	Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt	Bonus Filing OrganizationBonusFilingOrganizationAmount	Bonus Related OrganizationsBonusRelatedOrganizationsAmt	Other Compensation Filing OrgOtherCompensationFilingOrgAmt	Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt	Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt	Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt	Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt	Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt	Total Compensation Filing OrgTotalCompensationFilingOrgAmt	Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt	Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt	Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
AARON KOWALSKI PHD
CHIEF EXECUTIVE OFFICER	$514,382	$0	$162,000	$0	$75,000	$0	$26,000	$0	$45,994	$0	$823,376	$0	$0	$0
STEVEN ST PETER
MANAGING DIRECTOR, T1D FUND	$394,125	$0	$318,766	$0	$0	$0	$23,201	$0	$14,926	$0	$751,018	$0	$0	$0
TIMOTHY DOYLE
COO/PRESIDENT/ASST TREAS (BEG 12/21)	$434,730	$0	$109,300	$0	$0	$0	$21,240	$0	$34,860	$0	$600,130	$0	$0	$0
HELEN ELLIAS
MANAGING DIRECTOR, T1D FUND	$314,474	$0	$215,194	$0	$0	$0	$17,876	$0	$45,903	$0	$593,447	$0	$0	$0
TROY LINDLOFF
CDO/ASST. TREASURER (END 11/21)	$442,235	$0	$0	$0	$57,875	$0	$15,582	$0	$2,117	$0	$517,809	$0	$0	$0
CYNTHIA RICE
CHIEF MISSION OFFICER	$327,838	$0	$20,000	$0	$0	$0	$15,690	$0	$24,191	$0	$387,719	$0	$0	$0
JOANNE MARTZ
CFO/TREASURER (END 5/21)	$129,955	$0	$0	$0	$218,736	$0	$10,833	$0	$13,652	$0	$373,176	$0	$0	$0
SANJOY DUTTA PHD
CHIEF SCIENTIFIC OFFICER	$289,769	$0	$56,000	$0	$0	$0	$18,140	$0	$2,325	$0	$366,234	$0	$0	$0
GILLIAN GREEN
VP LEADERSHIP GIVING	$270,511	$0	$33,000	$0	$0	$0	$13,943	$0	$33,733	$0	$351,187	$0	$0	$0
CRAIG ROBERTSON
VP, FIELD DEVELOPMENT	$266,233	$0	$44,300	$0	$0	$0	$13,693	$0	$17,584	$0	$341,810	$0	$0	$0
YURY KUKUSHKIN
MANAGING DIRECTOR, T1D FUND	$220,416	$0	$90,215	$0	$0	$0	$13,960	$0	$1,223	$0	$325,814	$0	$0	$0
SYDNEY YOVIC
CHIEF OF STAFF/ASSISTANT SECRETARY	$215,812	$0	$44,000	$0	$0	$0	$12,012	$0	$32,399	$0	$304,223	$0	$0	$0
SRINIVAS MISHRA
CHIEF TECH OFFICER (END 8/21)	$245,705	$0	$0	$0	$0	$0	$11,367	$0	$16,643	$0	$273,715	$0	$0	$0
ANNE GEHRING
CONTRACT CFO (BEG 5/21, END 10/21)	$174,363	$0	$0	$0	$0	$0	$0	$0	$0	$0	$174,363	$0	$0	$0

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
PART I, LINE 1A	HOUSING ALLOWANCE CEO AARON KOWALSKI RECEIVED A TAXABLE HOUSING ALLOWANCE AS PER THE TERMS OF HIS EMPLOYMENT AGREEMENT. THE TOTAL FOR FY 2022 WAS $75,000.
PART I, LINE 4A	SEVERANCE PAYMENTS JOANNE MARTZ AND TROY LINDLOFF BOTH RECEIVED SEVERANCE PAYMENTS AS PER THE TERMS OF THEIR EMPLOYMENT AGREEMENTS. THE TOTALS FOR BOTH ARE AS FOLLOWS: JOANNE MARTZ - $218,736 TROY LINDLOFF - $57,875 SEVERANCE PAYMENTS ARE REPORTED ON SCHEDULE J, PART II, COL. (B)(III) AS OTHER REPORTABLE COMPENSATION.
SCHEDULE J, PART I, LINE 7	NON-FIXED PAYMENTS JDRF AWARDS NON-FIXED PAYMENTS SUCH AS BONUSES ON A DISCRETIONARY BASIS TIED TO THE EMPLOYEES' PERFORMANCE. THE NAMES OF EMPLOYEES AND THE AMOUNTS THAT WERE PAID ARE FOUND ON SCHEDULE J, PAGE 2, PART II, COL. (B) (II).

Schedule L IRS990ScheduleL

Bus Tr Involve Interested Prsn BusTrInvolveInterestedPrsnGrp (2 entries)

Relationship DescriptionRelationshipDescriptionTxt	TransactionTransactionAmt	TransactionTransactionDesc	Sharing Of RevenuesSharingOfRevenuesInd
STANTON BLACKWELL
SEE BELOW	$581,287	SEE BELOW	0
E BEARD
SEE BELOW	$60,386	SEE BELOW	0

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	SCHEDULE L, PART IV, LINE 1	FormAndLineReferenceDesc
Explanation	(B) ANNE GEHRING WAS CONTRACT CFO AND THEREFORE TREASURER OF THE BOARD FOR SEVERAL MONTHS WHILE THE CFO VACANCY WAS FILLED. SHE IS A FOUNDING PARTNER OF STANTON BLACKWELL, A CONSULTING FIRM ENGAGED BY JDRF FOR VARIOUS ADVISORY SERVICES. (C) REPRESENTS NON-CFO SERVICES PAID BY JDRF.(D) JDRF PAID STANTON BLACKWELL FOR CONTRACT/INTERIM CFO SERVICES PERFORMED BY ANNE GEHRING, WHO IS A FOUNDING PARTNER OF STANTON BLACKWELL AND FOR OTHER NON-CEO ADVISORY SERVICES.(B) E. BEARD HAS A FAMILY RELATIONSHIP WITH GRANT BEARD, A MEMBER OF JDRF'S BOARD OF DIRECTORS.(D) EMPLOYMENT BY JDRF.	ExplanationTxt

Schedule M IRS990ScheduleM

Securities Publicly Traded SecuritiesPubliclyTradedGrp

Field	Value	IRS element (for citing)
Non Cash Checkbox	Yes (X)	NonCashCheckboxInd
Contribution	278	ContributionCnt
Noncash Contributions Rpt F990	$5,611,770	NoncashContributionsRptF990Amt
Method Of Determining Revenues	NET PROCEEDS OF SALE	MethodOfDeterminingRevenuesTxt

Field	Value	IRS element (for citing)
Form8283 Received	0	Form8283ReceivedCnt
Any Property That Must Be Held	0	AnyPropertyThatMustBeHeldInd
Review Process Unusual NC Gifts	Yes (1)	ReviewProcessUnusualNCGiftsInd
Third Parties Used	Yes (1)	ThirdPartiesUsedInd

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDesc

ExplanationExplanationTxt

SCHEDULE M, PART I, LINE 32B

THIRD PARTY ASSISTANCE CHARITABLE ADULT RIDES AND SERVICES (CARS) IS A THIRD PARTY CAR DONATION COMPANY THAT HANDLES ALL ASPECTS OF CARS BEING DONATED TO JDRF. DONORS CALL A TOLL FREE NUMBER AND ARE PUT IN CONTACT WITH A TOWING SERVICE IN THEIR AREA. AFTER THE CAR IS DONATED, CARS HANDLES ALL IRS 1098-C REPORTING. FOR THE YEAR ENDED 6/30/2022, CARS RAISED $186,460, WITH SELLING EXPENSES OF $20,763 AND FUNDRAISING SERVICE FEES OF $33,140. JDRF DOES NOT PAY CARS ANY EXPENSES OR FEES DIRECTLY. JDRF RECEIVED $132,557 OF NET REVENUE FROM CARS IN FY 2022.

SCHEDULE M, PAGE 1

PART I, LINE 9 REPORTS THE NUMBER OF CONTRIBUTIONS OF SECURITIES THAT WERE MADE TO JDRF.

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (8 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
FORM 990, PART I, LINE 1 AND PART III, LINE 1 - ORGANIZATION'S MISSION	AT JDRF, WE WORK TIRELESSLY TO ACCELERATE BREAKTHROUGHS TO CURE, PREVENT AND TREAT TYPE 1 DIABETES (T1D). WE CONTINUALLY EXPAND OUR SCIENTIFIC KNOWLEDGE, OUR CONNECTIONS AND COLLABORATIONS, OUR PARTNERS AND GLOBAL PRESENCE TO UNLOCK THE SCIENCE THAT WILL STOP T1D. WHILE WE FIGHT FOR A CURE, WE STRIVE JUST AS HARD TO DEVELOP THERAPIES TO HELP PEOPLE RIGHT NOW. JDRF AND OUR SCIENTISTS ARE LEADING T1D RESEARCH AROUND THE WORLD. WE ADDRESS KEY GAPS TO MOVE RESEARCH FASTER AND FARTHER ACROSS THE DEVELOPMENT PIPELINE AND TO TRANSLATE BREAKTHROUGHS INTO NEW THERAPIES FOR PEOPLE WITH T1D. THIS ENABLES US TO ADVANCE SCIENCE WITH THE MOST POTENTIAL AND TO DRIVE RESEARCH THAT ATTRACTS MORE RESOURCES AND SCIENTIFIC EXPERTISE TO THE FIELD. WE INVEST IN THE EARLY STAGES, ALLOWING RESEARCHERS TO PURSUE INNOVATIVE IDEAS AND APPROACHES THAT WILL LEAD TO BREAKTHROUGH TREATMENTS. JDRF ALSO WORKS TO DRIVE NEW THERAPIES AND TECHNOLOGIES TO MARKET SO THEY GET INTO THE HANDS OF PEOPLE WITH T1D MORE QUICKLY. AND WE CONNECT THE T1D COMMUNITY TO CREATE A GLOBAL COMMUNITY OF SUPPORT FOR ANYONE AFFECTED BY T1D. FROM FUNDING INNOVATIVE RESEARCH TO ADVOCATING FOR GOVERNMENT ACTION AND PROVIDING A SUPPORT STRUCTURE FOR OUR COMMUNITY, NO OTHER ORGANIZATION DOES MORE TO FIGHT T1D THAN JDRF. SINCE OUR FOUNDING, JDRF HAS FUNDED MORE THAN $2.1 BILLION IN RESEARCH AND HAS MADE SIGNIFICANT PROGRESS IN UNDERSTANDING AND FIGHTING THE DISEASE. OUR ACTIONS - THROUGH ADVOCACY AND OUR OWN INVESTMENTS IN T1D RESEARCH - INFLUENCE OTHER ORGANIZATIONS, CORPORATIONS AND GOVERNMENT AGENCIES TO FOLLOW OUR LEAD AND DIRECT ADDITIONAL FUNDING TOWARD T1D RESEARCH. TODAY, EVERY $1 JDRF INVESTS IN RESEARCH ATTRACTS AN ADDITIONAL $7.42 TO THE FIELD. FOR FISCAL YEAR 2022, JDRF'S APPROXIMATELY $97 MILLION IN DIRECT FUNDING ATTRACTED $375 MILLION IN ADDITIONAL INVESTMENT IN T1D RESEARCH FROM U.S. AND INTERNATIONAL GOVERNMENT, NGOS AND CHARITABLE ORGANIZATIONS, AND CORPORATE PARTNERS.
FORM 990, PART III, LINE 4A: RESEARCH GRANTS	JDRF HAS PLAYED A SIGNIFICANT ROLE IN NEARLY EVERY T1D ADVANCEMENT--DRUG, DEVICE, CELL THERAPY--MADE IN THE LAST 50 YEARS. OUR FUNDING SUPPORTS MORE THAN 330 ACTIVE T1D RESEARCH GRANTS IN THE UNITED STATES AND 21 OTHER COUNTRIES AROUND THE WORLD, INCLUDING MORE THAN 160 GRANTS IN FY2022 ALONE, PLUS 66 CLINICAL TRIALS. WE LEVERAGE PARTNERSHIPS WITH ACADEMIA, INDUSTRY, AND CLINICIANS TO ACCELERATE THE MOST PROMISING RESEARCH OPPORTUNITIES. OUR HIGHEST PRIORITY IS DEVELOPING CURES FOR T1D AND IMPROVING LIVES OF THOSE LIVING WITH THE DISEASE TODAY, INCLUDING RESEARCH IN GLUCOSE CONTROL AND PREVENTION OF T1D COMPLICATIONS. THE FULL IMPACT OF JDRF'S RESEARCH INVESTMENT EXTENDS WELL BEYOND DIRECT FUNDING. THROUGH ADVOCACY AND INFLUENCE, JDRF DRIVES FUNDING FROM OTHER SOURCES INTO T1D RESEARCH AND HAS HELPED SECURE PASSAGE OF THE SPECIAL DIABETES PROGRAM, PUTTING MORE THAN $3 BILLION IN FEDERAL FUNDING TOWARD T1D RESEARCH OVER THE LAST TWO DECADES. IN ADDITION, JDRF FOUNDED THE JDRF T1D FUND (WWW.T1DFUND.ORG). A WHOLLY OWNED ENTITY OF JDRF, THE T1D FUND IS A VENTURE PHILANTHROPY FUND ACCELERATING LIFE-CHANGING SOLUTIONS TO TREAT, PREVENT, AND CURE T1D THROUGH CATALYTIC COMMERCIAL INVESTMENTS. THROUGH ITS INVESTMENTS IN PARTNERSHIP WITH PRIVATE CAPITAL, INCLUDING VENTURE CAPITAL, PHARMA, AND FOUNDATIONS, THE T1D FUND SEEKS TO ATTRACT THE PRIVATE INVESTMENT NECESSARY TO ADVANCE DRUGS, DEVICES, DIAGNOSTICS, AND VACCINES TO HELP PEOPLE LIVING WITH T1D AND THOSE WHO ARE AT RISK OF DEVELOPING THE DISEASE. THE T1D FUND INVESTS IN OPPORTUNITIES THAT DRIVE OUR MISSION, WITH AN EXCLUSIVE FOCUS ON THE MOST PROMISING COMMERCIAL OPPORTUNITIES. ALL FUNDS GO DIRECTLY TO SUPPORT COMPANIES DEVELOPING APPROACHES TO TREAT, PREVENT, AND CURE T1D. IN ACCORDANCE WITH GAAP, $11.8 MM OF THE T1D FUND'S TOTAL INVESTMENTS AS OF JUNE 30, 2022, ARE REFLECTED IN THE BALANCE SHEET (PART X) AND NOT INCLUDED WITHIN THE ORGANIZATION'S RESEARCH - RELATED MISSION EXPENSE. THE FOUNDATION'S DIVERSIFIED RESEARCH PORTFOLIO INCLUDES A FOCUS ON CURING T1D AND IMPROVING LIVES. CURING T1D WE FACE TWO KEY CHALLENGES IN CURING T1D. WE MUST PREVENT, STOP, OR REVERSE THE (1) LOSS OF INSULIN-PRODUCING BETA CELLS AND (2) THE IMMUNE SYSTEM'S ATTACK ON BETA CELLS. JDRF IS ACCELERATING OUR WORK IN CURING T1D BY FOCUSING ON THREE AREAS THAT HAVE ADVANCED DRAMATICALLY OVER THE YEARS: SCREENING FOR RISK OF T1D, CELL THERAPIES, AND DISEASE-MODIFYING THERAPIES. SCREENING FOR RISK OF T1D: FOCUS ON EXPANDING SCREENING FOR T1D-RELATED AUTOANTIBODIES AND SCREENING AWARENESS. DONOR-FUNDED RESEARCH HAS DISCOVERED THAT HAVING TWO OR MORE T1D-SPECIFIC ANTIBODIES MEANS THAT YOU HAVE AN ALMOST 100% CHANCE OF DEVELOPING DIABETES IN YOUR LIFETIME. WITH ONE BLOOD TEST, YOU CAN FIND OUT--BEFORE SYMPTOMS APPEAR--IF YOU ARE AT RISK. THIS CAN REDUCE THE RISK OF DIABETIC KETOACIDOSIS AND HOPITALIZATION AT THE ONSET OF SYMPTOMS AND IDENTIFY PEOPLE WHO CAN TAKE PART IN CLINICAL TRIALS TO DELAY OR PREVENT T1D. CELL THERAPIES: FOCUS ON REPLACING INSULIN-PRODUCING BETA CELLS FROM OUTSIDE SOURCES SUCH AS STEM CELLS OR NON-HUMAN CELLS. THROUGH DONOR-FUNDED RESEARCH, WE NOW KNOW THAT WHEN SOMEONE HAS T1D, THEIR OWN BODY BEGINS ATTACKING AND DESTROYING THE BETA CELLS THAT CREATE INSULIN. IF WE CAN SAVE OR REPLACE BETA CELLS, WE CAN HELP CURE T1D. THERE IS EARLY BUT CRUCIAL PROGRESS SEEN IN RECENTLY REPORTED CLINICAL TRIALS WHERE BETA CELL REPLACEMENT HAS MADE ADVANCES TOWARD INSULIN INDEPENDENCE, BETTER T1D CONTROL, AND LONGEVITY OF THE THERAPIES. DISEASE-MODIFYING THERAPIES: FOCUS ON WAYS TO KEEP THE IMMUNE SYSTEM FROM ATTACKING AND DESTROYING BETA CELLS, WAYS TO PROTECT AND SPUR THEM, AND DEVELOP TREATMENTS THAT CAN SLOW, HALT, OR REVERSE T1D, AT ANY AGE OR STAGE OF THE DISEASE. RESEARCH HAS SHOWN THAT IMMUNE THERAPIES CAN INTERACT WITH A PERSON'S IMMUNE SYSTEM, TRAINING IT TO COMBAT INTERNAL BATTLES THAT LEAD TO THE DESTRUCTION OF ITS OWN BETA CELLS. WHILE T1D REMAINS ONE OF THE FEW MAJOR AUTOIMMUNE DISEASES WITHOUT AN EFFECTIVE DRUG THERAPY TO CHANGE THE COURSE OF THE DISEASE, WE KNOW WE ARE GETTING CLOSE. IMPROVING LIVES T1D BRINGS WITH IT DAILY STRUGGLES AND STRESSES THAT THAT MAKE THE CHALLENGES OF LIVING A HEALTHY AND LONG LIFE WITH T1D VERY REAL. JDRF FIGHTS EVERY DAY TO ADVANCE RESEARCH THAT CAN REDUCE THE BURDEN OF LIVING WITH T1D AND KEEP PEOPLE AS HEALTHY AS POSSIBLE UNTIL WE FIND CURES. SPECIFICALLY, WE ARE STRIVING TO IMPROVE LIVES BY ACCELERATING THE DEVELOPMENT OF DRUGS, DEVICES, BEHAVIORAL HEALTH INTERVENTIONS, AND COMBINATIONS OF THESE, TO IMPROVE SHORT- AND LONG-TERM HEALTH OUTCOMES AND QUALITY OF LIFE, THROUGH THE FOLLOWING THREE PROGRAMS. GLUCOSE CONTROL: FOCUS ON HELPING THOSE WITH T1D MANAGE GLUCOSE LEVELS AND OVERALL METABOLIC BALANCE, INCLUDING IMPROVED ARTIFICIAL PANCREAS TECHNOLOGY, DEVELOPING NEXT-GENERATION INSULINS, AND DEVELOPING NEW DRUGS THAT CONTROL GLUCOSE AND OTHER METABOLIC FACTORS IN NOVEL WAYS. WE KNOW THAT FEWER THAN 30% OF PEOPLE WITH T1D IN THE U.S. CONSISTENTLY MAINTAIN TARGET BLOOD-GLUCOSE LEVELS--MEANING THAT 70% ARE AT RISK OF SERIOUS HEALTH ISSUES. AIMING TO ENSURE OUR COMMUNITY IS HEALTHY WHEN CURES ARE FOUND, WE WILL CONTINUE TO FOCUS ON NOVEL INSULINS, ADJUNCTIVE THERAPIES IN ADDITION TO INSULIN THAT MAKE IT EASIER TO LIVE WITH T1D, AND SMALLER, EASIER TO WEAR INSULIN PUMPS AND CONTINUOUS GLUCOSE MONITORS WITH IMPROVED ALGORITHMS THAT SHOULDER MORE OF THE BURDEN OF T1D. COMPLICATIONS: FOCUS ON ACCELERATING THERAPIES THAT PREVENT AND TREAT KIDNEY AND EYE DISEASE. WE KNOW THAT MORE THAN 90% OF PEOPLE WITH T1D DEVELOP SOME LEVEL OF EYE DISEASE WITHIN 20 YEARS OF DIAGNOSIS AND THAT 1 IN 4 DEVELOP KIDNEY DISEASE. JDRF WILL DIRECT FUNDS TO DEVELOP AND IMPROVE EYE AND KIDNEY DISEASE TREATMENTS, SO THAT PEOPLE AT RISK CAN TAKE STEPS TO INTERVENE EARLY IN THE DISEASE PROCESS. PSYCHOSOCIAL HEALTH: FOCUS ON REDUCING THE PSYCHOSOCIAL CHALLENGES OF T1D. EARLY RESEARCH HAS SHOWN THAT THE BURDEN OF LIVING WITH T1D TAKES A TOLL BEYOND THE PHYSICAL COMPLICATIONS, OFTEN AFFECTING PEOPLE'S SOCIAL, BEHAVIORAL, AND EMOTIONAL WELL-BEING, KNOWN COLLECTIVELY AS PSYCHOSOCIAL HEALTH. WE AIM TO REDUCE THE CHALLENGES THROUGH INCREASING THE NUMBER OF AND PROVIDING ACCESS TO PSYCHOLOGISTS TRAINED IN T1D, SUPPORTING RESEARCH INITIATIVES TO IMPROVE PSYCHOSOCIAL HEALTH AND OUTCOMES, AND EDUCATING THE T1D COMMUNITY ABOUT THE PSYCHOSOCIAL IMPACT OF THE DISEASE.
FORM 990, PART III, LINE 4B: RESEARCH SUPPORT	JDRF'S IN-HOUSE TEAM OF SKILLED AND CREDENTIALED SCIENTIFIC, POLICY, AND GOVERNMENT RELATIONS PROFESSIONALS PLAYS A CRITICAL ROLE IN LEADING AND SUPPORTING THE RESEARCH STRATEGY AND DISTRIBUTION OF RESEARCH FUNDS FROM JDRF--AND OUR PARTNER ORGANIZATIONS--TOWARD CREATING A WORLD WITHOUT T1D. OUR PROFESSIONALS IDENTIFY, EVALUATE, AND INFLUENCE GROUNDBREAKING RESEARCH FOR FUNDING AND WORK WITH OTHER FOUNDATIONS, GOVERNMENTS, AND INDUSTRY PARTNERS TO ACCELERATE THE MISSION WE ALL SHARE. JDRF PROFESSIONALS WORK WITH REGULATORY AND POLICY OFFICIALS TO ENSURE RESEARCH CAN PROCEED WITHOUT DELAY AND THAT ADVANCES ARE WELL UNDERSTOOD BY HEALTHCARE DECISION MAKERS. AS PART OF THESE EFFORTS, JDRF ORGANIZES AND FUNDS SCIENTIFIC MEETINGS, SYMPOSIA, AND CONFERENCES, TO ENSURE THAT JDRF'S RESEARCH STRATEGY IS ALIGNED WITH THE NEEDS OF THE T1D COMMUNITY AND ALLOW JDRF TO PROVIDE SCIENTIFIC UPDATES ON THE RESEARCH IT MANAGES. THIS EFFORT ENSURES THAT ALL THE RESEARCH IS CONTINUALLY SHARED AND BUILT UPON BY T1D RESEARCHERS AROUND THE GLOBE. THE STRATEGIC ADVISORY PANEL (SAP) IS COMPOSED OF FIVE ESTABLISHED T1D EXPERTS IN VARIOUS ASPECTS OF THE FIELD, INCLUDING PEDIATRIC ENDOCRINOLOGY, PREVENTION, AND TREATMENT OF T1D, IMMUNOTHERAPIES, REGULATORY, AND DRUG DEVELOPMENT. THE SAP CONTRIBUTES TO JDRF SCIENTISTS' STRATEGIC PLANNING AROUND RESEARCH FUNDING GOALS AND PRIORITIES. JDRF'S WORK TO BRING TOGETHER THE BEST MINDS IN THE FIELD ENHANCES JDRF'S ABILITY TO FORECAST FUTURE SCIENTIFIC DIRECTION, JUDGE THE POTENTIAL EFFECTIVENESS OF NEW PATHWAYS, AND IDENTIFY GAPS WHERE JDRF FUNDING CAN MAKE THE MOST IMPACT.
FORM 990, PART III, LINE 4C: PUBLIC EDUCATION	JDRF IS UNIQUELY QUALIFIED TO PROVIDE PUBLIC EDUCATION ABOUT DIABETES AND ITS COMPLICATIONS. JDRF'S EFFORTS IMPACT NOT ONLY THE MILLIONS OF PEOPLE LIVING WITH T1D, THEIR FAMILIES, AND THE GENERAL PUBLIC, BUT ALSO THOSE AT RISK FOR DEVELOPING THE DISEASE. T1D STRIKES BOTH CHILDREN AND ADULTS, AND THE CRITICAL ADJUSTMENT PERIOD FOLLOWING A DIAGNOSIS CAN BE OVERWHELMING. THAT'S WHY WE SUPPORT FAMILIES NAVIGATING THIS CHALLENGING TIME. JDRF ALSO EDUCATES PEOPLE ABOUT THE WARNING SIGNS OF T1D, AIMED AT ENSURING TIMELY DIAGNOSES AND REDUCING THE POTENTIAL CATASTROPHIC CONSEQUENCES OF UNDIAGNOSED T1D. JDRF ALSO PROVIDES INFORMATION AND UPDATES ABOUT CURRENT RESEARCH DIRECTIONS AND PROGRESS AND ABOUT HUMAN CLINICAL TRIALS THAT ARE SEEKING PARTICIPANTS (INCLUDING THROUGH JDRF'S CLINICAL TRIALS CONNECTION MATCHING TOOL: WWW.JDRF.ORG/RESEARCH/CLINICAL-TRIALS). THROUGH ALL OF OUR NATIONAL U.S. CHAPTERS; FIVE INTERNATIONAL AFFILIATES IN AUSTRALIA, CANADA, ISRAEL, THE NETHERLANDS, AND UNITED KINGDOM; THE 30,000 MEMBERS OF OUR SOCIAL NETWORK, TYPEONENATION; AND MORE THAN ONE MILLION SUPPORTERS, JDRF FIGHTS TO MEET THE T1D COMMUNITY'S DIVERSE NEEDS, CONNECTING PEOPLE WITH LOCAL SUPPORT, EXPERT RESOURCES, AND THE GLOBAL EFFORT TO CREATE A WORLD WITHOUT T1D.
FORM 990, PART VI, SECTION B, LINE 11B	FORM 990 REVIEW PROCESS JDRF HAS A RIGOROUS STANDARD APPROACH TO REVIEWING ITS 990. THE ORGANIZATION'S ACCOUNTING MANAGER WORKS WITH ITS OUTSIDE TAX PREPARERS TO PREPARE THE RETURN AND ALL SUPPORTING SCHEDULES. THE DRAFT RETURN IS REVIEWED BY A NUMBER OF INDIVIDUALS, INCLUDING JDRF'S CHIEF FINANCIAL OFFICER, OTHER EXECUTIVES, ITS EXTERNAL SENIOR TAX ADVISOR AND OTHERS AS NECESSARY TO ENSURE ACCURACY. ANY QUESTIONS AND CHANGES WITH RESPECT TO THE DRAFT RETURNS ARE ADDRESSED. FOLLOWING THIS PROCESS, THE RETURN IS REVIEWED BY JDRF'S AUDIT AND RISK COMMITTEE OF THE BOARD OF DIRECTORS WITH ITS OUTSIDE TAX ADVISORS. ONCE APPROVED, THE RETURN IS DISTRIBUTED TO ALL MEMBERS OF JDRF'S BOARD OF DIRECTORS FOR REVIEW AND COMMENT BEFORE IT IS FILED WITH THE INTERNAL REVENUE SERVICE.
FORM 990, PART VI, SECTION B, LINE 12C	COVERED PERSONS COMPLETE A CONFLICT OF INTEREST DISCLOSURE FORM AND ACKNOWLEDGE THE JDRF CODE OF ETHICS AT THE BEGINNING OF EACH FISCAL YEAR. COVERED PERSONS INCLUDE: MEMBERS OF THE INTERNATIONAL BOARD OF DIRECTORS, DIRECTORS EMERITUS, MEMBERS OF THE GLOBAL MISSION BOARD, CHAPTER DIRECTORS AND OFFICERS, DIRECTORS OF THE JDRF T1D FUND, AND MEMBERS OF THE T1D FUND INVESTMENT COMMITTEE. WHEN A CONFLICT IS DISCLOSED, THE COVERED PERSON SHALL ABSTAIN FROM PARTICIPATING IN DECISIONS AND/OR DISCUSSIONS INVOLVING JDRF'S BUSINESS OR RELATIONSHIP WITH THE RELEVANT THIRD PARTY. IF THE COVERED PERSON IS ASKED TO ABSTAIN, THE COVERED PERSON MAY STILL BE PERMITTED TO STATE HIS OR HER POSITION ON SUCH MATTER AND TO ANSWER PERTINENT QUESTIONS AND INQUIRIES RELATING THERETO. THE COVERED PERSON MAY BE ASKED TO LEAVE THE MEETING DURING THE DISCUSSION OF AND/OR VOTE ON THE MATTER INVOLVING THE RELEVANT THIRD PARTY.
FORM 990, PART VI, SECTION B, LINE 15	EXECUTIVE COMPENSATION POLICY JDRF'S BOARD OF DIRECTORS CHARGES A TALENT AND COMPENSATION COMMITTEE TO DEVELOP AND RECOMMEND A COMPENSATION PHILOSOPHY THAT APPLIES TO ALL EMPLOYEES OF JDRF, INCLUDING RECOMMENDATIONS REGARDING THE COMPENSATION AND BENEFITS OF JDRF SENIOR MANAGEMENT FOR APPROVAL BY THE BOARD OF DIRECTORS. THE COMMITTEE WORKS IN COLLABORATION WITH THE PRESIDENT AND CEO AND THE CHIEF HUMAN RESOURCES OFFICER AND OTHER SENIOR STAFF PERSONNEL IN THE JDRF HUMAN RESOURCES DEPARTMENT TO ENSURE THAT 1) THE FOUNDATION'S TALENT STRATEGY SUPPORTS AND IS ALIGNED WITH ITS OVERALL ORGANIZATION STRATEGIES; 2) JDRF IS IN COMPLIANCE WITH IRS GUIDELINES FOR DETERMINING REASONABLENESS IN PAY PRACTICES; AND 3) OVERALL COMPENSATION FOR JDRF'S KEY EXECUTIVES IS COMPETITIVE AND ALIGNED WITH PAY PHILOSOPHY. TO ATTRACT AND RETAIN TOP SCIENTIFIC AND EXECUTIVE TALENT TO ADVANCE ITS MISSION, THE ORGANIZATION PAYS COMPETITIVE AND APPROPRIATE SALARIES AS DETERMINED BY ANALYSIS OF RELIABLE DATA AND INPUT FROM INDEPENDENT THIRD-PARTY CONSULTANTS. THE REVIEW OF JDRF EXECUTIVE COMPENSATION AND BENEFITS UNDER THE PROCEDURES NOTED ABOVE IS COMPLETED ANNUALLY BY AN INDEPENDENT COMPENSATION COMMITTEE, AND THE BASIS FOR THEIR DETERMINATION IS DOCUMENTED CONTEMPORANEOUSLY IN THE MINUTES OF THE COMMITTEE'S MEETINGS, INCLUDING MOST RECENTLY ON JUNE 30, 2022.
FORM 990, PART VI, SECTION C, LINE 19	PUBLIC DOCUMENTS THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC ON ITS WEBSITE: WWW.JDRF.ORG. THE PUBLIC MAY ACCESS COPIES OF JDRF'S W-9, ANNUAL REPORTS, 990 TAX RETURNS, 501(C)(3) IRS LETTER, AND AUDITED FINANCIALS, AT THE FOLLOWING LINK: WWW.JDRF.ORG/ABOUT/FINANCIALS.

Schedule R IRS990ScheduleR

Id Disregarded Entities IdDisregardedEntitiesGrp

Disregarded Entity Name DisregardedEntityName

Field	Value	IRS element (for citing)
Business Name Line1	JDRF T1D FUND LLC	BusinessNameLine1Txt

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	C/O JDRF - 200 VESEY ST 28TH FL	AddressLine1Txt
City	NEW YORK	CityNm
State Abbreviation	NY	StateAbbreviationCd
ZIP	10281	ZIPCd

Field	Value	IRS element (for citing)
EIN	274967989	EIN
Primary Activities	FUNDR/INVEST	PrimaryActivitiesTxt
Legal Domicile State	DE	LegalDomicileStateCd
Total Income	$5,969,622	TotalIncomeAmt
End Of Year Assets	$163,269,000	EndOfYearAssetsAmt

Direct Controlling Entity Name DirectControllingEntityName

Field	Value	IRS element (for citing)
Business Name Line1	JDRF	BusinessNameLine1Txt

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	SCHEDULE R, PART I, LINE (1B)	FormAndLineReferenceDesc
Explanation	THE PRIMARY ACTIVITY FOR THE JDRF T1D FUND IS FUNDRAISING AND INVESTING IN TYPE ONE DIABETES RESEARCH. PLEASE SEE DETAILED DESCRIPTION ON SCHEDULE O, PART III, LINE 4A, STATEMENT OF PROGRAM SERVICE ACCOMPLISHMENTS FOR RESEARCH GRANTS.	ExplanationTxt